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Abstract
Understanding how an epigenetic regulator such as ATP-dependent chromatinremodeling complexes modulate processes such as development and/or immune
response is essential for our comprehension of cell biology. Deletion of the ATPdependent chromatin remodeling factor INO80 is known to be embryonically lethal,
however, the mechanism is not known. To identify roles for INO80 in mouse early
development we generated Ino80 KO mice. Ino80 KO ESCs (Embryonic stem cells)
were viable when maintained at ground state pluripotency but fail to differentiate in vitro
and in vivo. Gene expression analysis of Ino80 KO early embryos by in situ
hybridization showed elevated Bmp4 expression and reduced expression of DVE (distal
visceral endoderm) markers Cer1, Hex, and Lefty1. BMP4 is a known negative regulator
of DVE differentiation in the early embryo. Molecular studies in Ino80 KO ESCs
demonstrated that INO80 is bound to the Bmp4 promoter, and regulates its chromatin
structure, to suppress the positive regulator SP1 from stimulating its transcription.
These results, suggest that INO80 directly regulates the chromatin structure of
the Bmp4 promoter with consequences to mouse embryo development. These results
are significant because they demonstrate a specific role of INO80 in establishing P-D
embryonic axis.
NURF (Nucleosome remodeling factor) is another ATP-dependent chromatin
remodeling complex that is overexpressed in many cancer types including breast
cancer. To demonstrate the roles of NURF in breast cancer biology, we knocked-down
the NURF essential subunit BPTF (bromodomain PHD finger transcription factor) in
1

mouse breast cancer cell lines. Transplantation of these cell lines into immunecompetent mice revealed that BPTF KD enhances NK cell antitumor activity. BPTF KD
enhanced NK-92 cytotoxic activity toward BPTF KD cells by NKp30 activation in vitro.
NK-92 activity is reduced by the addition of heparin to the culture medium, further
indicating the involvement of NKp30 (in human) and NCR1 (in mice) in killing of tumor
cells. We found that BPTF controls the abundance of NKp30/NCR1 ligands (heparin
sulfate proteoglycans (HSPGs) by regulation of heparanase expression
(endoglycosidase that degrades HSPGs). In addition, BPTF depletion in established
mouse breast tumors enhanced anti-tumor immunity, without affecting NK or T cell
cytotoxic activity, providing a novel immunotherapy target.
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PART I. Role of the Nucleosome Remodeling Factor INO80 in Development
Chapter 1. Background and Literature Review

1.1 DNA Packaging into Chromatin
The eukaryotic genetic information is stored in two meters of linear DNA. In order
for this long DNA to fit into a 10 µm nucleus it has to be packaged into chromatin, which
consists of DNA wrapped around histone proteins. Histone proteins are highly
conserved proteins, and they are the main components of chromatin structure. The
basic unit of chromatin structure is the nucleosome, which is composed of 145-147 bp
DNA wrapped around an octamer of histones, which itself consists of two copies of the
canonical histones H2A, H2B, H3, and H4. The nucleosome structure is stabilized by
the interaction between negatively charged DNA and positively charged histones. It is
also stabilized by the protein-protein interactions inside the histone octamer (Davey et
al., 2002 and Rohs et al., 2009). Nearby nucleosomes are connected by linker DNA (1090 bp) and linker histones (H1 and H5) to form a chromatin fiber. Interactions between
these fibers through inter and intra-nucleosomal interactions give rise to the highly
compacted chromatin that we see in the chromosomes (Tremethick et al., 2007).
Depending on the degree of chromatin condensation, chromatin can be divided
into euchromatin and heterochromatin (Trojer and Reinberg, 2007). Euchromatin is less
condensed chromatin and enriched with genes. Heterochromatin is highly condensed
and can be further divided into constitutive and facultative heterochromatin
3

(Margueron et al. 2005). Constitutive heterochromatin is repetitive DNA sequences that
are clustered at telomeres, centromeres and peri-centromeric regions of the
chromosomes. Facultative heterochromatin is enriched with genes that are expressed
at a specific developmental stage or in response to specific stimuli. Consequently,
regions of facultative heterochromatin are different among different cell types. These
different chromatin domains are separated from each other by insulator elements
(Trojer and Reinberg, 2007). Chromatin in its high order structure is inaccessible to DBP
(DNA binding proteins), which are involved in nuclear processes such as transcription,
DNA replication, and DNA damage response. Therefore, cells have evolved
mechanisms to modulate the chromatin from inaccessible to accessible conformation,
which includes histone modifications, DNA methylation, incorporation of histone
variants, ATP-dependent chromatin remodeling, and long non-coding RNA mediated
modulation (C. David and Thomas, 2016).

1.2 Mechanisms of Chromatin Structure Modulation
1.2.1 Histone Modifications
Histones are chemically modified at the post-translation level mostly at their Nterminal and to a lesser extent at core residues or C-termini. The N-termini of histones
is about 19-40 amino acids enriched in basic residues mainly lysine (K) and arginine (R)
that are extended out from the nucleosome in the form of histone tails. The interaction
between these tails in neighboring nucleosomes, or within the same nucleosome, help
to modulate chromatin structure. Post-translation modification (PTM) of histones could
4

be in the form of methylation, acetylation, phosphorylation or ubiquitination. The
presence of these modifications serve as a platform for the recruitment of chromatin
modulators or transcription factors (Andrew and Tony, 2011).
Methylation occurs mostly on lysine and to a lesser extent on arginine.
Methylation can be mono-, di-, or tri- and the methylated residue can be on K4 or K36,
which are associated with active chromatin, or on K9/K27, which are associated with
repressed chromatin. Genome-wide analysis showed that H3K4me3 is localized at
active TSS (transcription start sites) considering them as mark of active promoters
(Sims et al., 2005). H3K4me1 is co-localized at enhancers with p300 histone acetyl
transferase. The presence of active methylation marks serves to recruit chromatin
remodeling complexes, such as NURF or the CHD1 (chromo-domain helicase DNA
binding1), to promoter regions to facilitate gene expression (Wysocka et al., 2006). The
H3K36me3 mark is enriched at exons than introns, suggesting a possible role in
alternative splicing or the transcript elongation (Barski et al., 2007, Spies et al., 2009
and Kolasinska et al., 2009).
Acetylation mainly occurs on lysine residues and many studies showed that H4
and H3 acetylation is a mark of open and accessible chromatin domains. ShogrenKnaak et al., showed that acetylation on H4K16 interferes with chromatin compaction
(Shorgen-Knaak, et al., 2006). In addition, acetylation neutralizes the positively charged
lysine residues on histone tails and weaken their interaction with negatively charged
DNA, which facilitate chromatin accessibility (Luger et al., 1997). Cells with highly
dynamic chromatin, like ESCs, have enrichment of H4K16ac at TSS of transcriptionally
active genes (Taylor et al., 2013).
5

Phosphorylation of histones can occur on serine, threonine and tyrosine
residues, and this modification plays a role in many processes such as chromatin
compaction, DNA repair, and transcription. The most conserved form of histone
phosphorylation in eukaryotes is H3 phosphorylation. Four residues are phosphorylated
on the H3 N-termini, which are T3, S10, T11, and S28. However, the most documented
mark is H3S10ph (histone 3 phosphorylation at serine 10). H3S10ph is associated with
chromatin condensation during mitosis (Wei et al., 1999). In addition, the linker histone
H1 is phosphorylated in a cell cycle-dependent manner especially during mitosis. H1
phosphorylation by the CDC2 kinase mediates its binding to HP1 to maintain more
stabilize compacted chromatin structure while its phosphorylation by CDK2 disrupt this
interaction and destabilize chromatin to promote cell progression (Hale et al., 2006).
Moreover, the phosphorylation of H3S28 is involved in transcription regulation of EGF
(epidermal growth factor)-responsive genes such as c-fos (Lau et al., 2011). In
response to DNA damage, the histone variant H2AX is phosphorylated by the ATM
kinase and it is commonly referred to as γH2AX. The phosphorylation of H2AX spreads
around the DNA damage site to recruit repair proteins such as MDC1 (Stucki et al.,
2005)
Ubiquitination occurs in the form of mono-ubiquitination on lysine residues. The
most ubiquitinated histones in the nucleus are H2A and H2B. H2Aub is associated with
repressed chromatin since H2Aub ligase is found in repression complexes such as
PRC1 (polycomb repressive complex) (Ogawa et al., 2002). Another study showed that
H2Aub prevents the recruitment of the histone chaperon FACT (facilitate chromatin
6

transcription) to RNAP II binding sites to facilitate transcription elongation (Zhou et al.,
2008). In addition, the activity of H2A deubiquitinase (2A-DUB) in activating gene
expression provides another supporting evidence for H2Aub associated repression
(Zhu et al., 2007). However, H2Bub is mostly associated with gene activation. ChIP-chip
experiments showed enrichment of H2Bub at actively transcribed genes (Minsky et al.,
2008). ChIP-chip is chromatin immunoprecipitation (ChIP) followed by DNA microarray
(chip) to identify the interactions between DNA and proteins in a genome wide scale
(Aparicio et al., 2004). H2Bub is also involved in transcription elongation where they are
required for maintaining the chromatin integrity during elongation by RNA Pol II (Xiao et
al., 2005).
1.2.2 Incorporation of Histone Variants
Histone variants are different from canonical histones mainly at the C-termini by
length or amino acid composition (Ausió et al., 2002). The replacement of canonical
histones with histone variants alter the nucleosome structure and consequently its
function. For example, the replacement of H2A with its variants which includes H2AZ,
H2AX, H2ABBD (H2A-bar-body-deficient) and macro H2A alters cellular functions in
diverse cellular pathways. H2AZ (Htz1 is the yeast homolog) is the most studied H2A
variant, and it is encoded by an essential gene since its disruption in mice resulted in
early embryonic lethality (Faast et al., 2001). H2AZ is required to maintain
heterochromatin domains through preventing the spread of HP1 to active regions in the
genome (Rangasamy et al., 2004). H2AZ incorporation modulates chromatin structure
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to facilitate active transcription and as such, its incorporation prevents chromatin
condensation (Park et al., 2004).
1.2.3 DNA Methylation
DNA modification by methylation is the major form of epigenetic regulation in
which the cytosines is covalently linked to a methyl group at the primary sequence CpG
dinucleotide. DNA methylation patterns are tissue- and cell type-specific through
methylation of CpG at specific sites (Razin et al., 1980). DNA methylating enzymes
Dnmt3a and Dnmt3b are involved in the de novo establishment of methylation during
development while the Dnmt1 is required to maintain this pattern upon cell division.
DNA methylation pattern affect the chromatin structure since hypomethylated DNA is
associated with active chromatin while hypermethylated DNA is associated with
repressed chromatin (Razin et al., 1977). DNA methylation silences gene expression by
impeding the binding of positive transcription factors or the recruitment of MBPs
(methylated DNA binding proteins), which in turn recruit a repressive complexes that
silences gene expression. For example, the chromatin remodeling complex NURD
(Nucleosome remodeling and histone deacetylase) contain MBD2 (Methyl binding
domain 2) that binds methylated DNA, and this interaction stabilizes MBD2 binding and
represses gene expression (Zhang et al., 1990). Chromatin modification drives specific
DNA methylation, and there is a growing evidence for the interaction between histonemodifying enzymes, such as HDAC1 (Histone deacetylase 1) and HDAC2 (Histone
deacetylase 2), and the DNA methylating enzymes Dnmt1, Dnmt3a (Fuks et al., 2000).
For example, transcription factors induce specific genes acetylation by recruitment of
8

HATs (Histone acetyl transferases) and RNA Pol II, and this is followed by DNA
demethylation (D'Alessio et al., 2007).
1.2.4 ATP-Dependent Chromatin Remodeling Complexes
The major regulators of chromatin structure are complexes that utilize ATP
hydrolysis as an energy source to disrupt histone-DNA interaction, and they are known
as ATP-dependent chromatin remodeling complexes. These complexes are involved in
every aspect of genome metabolism such as transcription, DNA replication, gene
expression, and DNA damage and repair responses. These complexes belong to the
Snf2 (sucrose non-fermenting 2) family of ATP-dependent helicases, which is further
divided into four subfamilies based on the sequence homology of the ATPase domain
and additional domains within the ATPase subunit, which include SWI/SNF (Switching
defective 2/sucrose non-fermenting 2) ISWI (Imitation switch); CHD (Chromodomain,
helicase and DNA-binding) and INO80 (Inositol-requiring 80). All subfamilies share the
highly conserved ATPase domain, including an ATP binding domain for enzymatic
activity adjacent to a helicase domain, which is required for the remodeling function
(Bartholomew et al., 2014). The remodeling activity could result in the sliding of a
nucleosome, nucleosome eviction, nucleosome assembly, nucleosome spacing or
exchanging histone variants as showed in Figure 1.1. Sliding can expose or mask
transcription factor binding sites in DNA. Ejecting a nucleosome is required during
nuclear processes such DNA replication, and the DNA damage response. Exchange of
histone variants occurs when modulating the nucleosome structure, such as the
deposition of γH2AX variant of H2A during a DNA damage response (Becker et al.,
2013).
9

Figure 1.1: The Effect of ATP-Dependent Nucleosome Remodeling.
A) Remodeling can result in change of position or composition of nucleosomes.
B) ATP-dependent remodeler can cooperate with histone chaperones to assemble nucleosomes.
C) ATP-dependent remodeler can arrange the distances between nucleosomes during nucleosome
spacing. (Becker et al., 2013).

10

1.3 Chromatin Remodeling and Development
ATP-dependent chromatin remodeling complexes are crucial for chromatin
dynamic structure (assembly & disassembly) and regulation. Now, it is conceivable that
these complexes have evolved as an adaptation to the major changes in chromatin
regulation. During their evolution, they have expanded their gene families and utilized
different combinatorial assemblies to form several hundred complexes with diverse
biological functions beyond transcription in a different context (Wu et al., 2009).
1.3.1The SWI/SNF or BAF Complexes
BAF complexes change their subunit composition during ESCs differentiation
from pluripotent to multipotent progenitor cell to a unipotent committed cell. The ATPase
subunit of BAF complexes is encoded by two genes, Brm and Brg1 (Brahma-related
gene 1), and each complex contains only one of them. BAF complexes with different
ATPase subunit exhibit diverse roles in different cell types (Lessard et al., 2007). In
mammals, mRNA of oocytes is degraded after fertilization and zygote genes must be
activated to initiate cell division. Brg1 is crucial for zygotic gene activation and, maternal
KO of Brg1 results in four-cell stage embryo that cannot undergo cleavage division
(Scott et al., 2006). Brg1 null embryos die before implantation stage where Brg1 is
required for ICM (inner cellular mass) and trophoblast cell survival through regulation of
self-renewal and pluripotency genes (Scott et al., 2000). However, Brm null embryos
develop normally with increased body weight that could be a result of high proliferation
rates. Brm null MEFs fail to arrest the cell cycle in response to cell confluency or DNA
11

damage, suggesting that Brm is involved in the regulation of cell growth (Reyes et al.,
1998).
1.3.2 ISWI Complexes
The core ATPase of ISWI complexes is SNF2H or SNF2L, which are found in
different complexes with distinct functions. Both NURF and CERF (CECR2- Containing
Remodeling Factor) complexes contain the SNF2L ATPase. Whereas the NoRC
(Nucleolar Remodeling Complex) and the WICH (WSTF ISWI Chromatin Remodeling),
ACF (ATP-Utilizing Chromatin Assembly and Remodeling Factor) and CHARC
(Chromatin Remodeling by Chromatin Accessibility Complex) complexes contain the
SNF2H ATPase. Embryos null for BPTF (Bromodomain PHD Finger Transcription
Factor), the largest NURF complex subunit that is required for complex assembly, did
not survive beyond the E8.5 days with the absence of DVE and AVE markers. Although
BPTF null mESCs are viable, they fail to differentiate into endoderm or mesoderm
(Landry et al., 2008). Knock-out of the remodeling subunit CECR2 in mice also resulted
in neural tube defects in a strain-specific manner (Banting et al., 2005). Homozygous
inactivation of the SNF2H resulted in embryo lethality after implantation since SNF2H is
essential for the survival of ICM and trophoblast cells (Tomas et al., 2003).
1.3.3 CHD Complexes
The CHD complexes are classified into three subfamilies: subfamily I (CHD1 and
CHD2), subfamily II (CHD3 and CHD4) and subfamily III (CHD5, CHD6, CHD7, CHD8
and CHD9). In mice, Chd1 knock-out is lethal before implantation due to loss of
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pluripotency. Depletion of CHD1 in bovine embryo reduced the number of blastocysts at
early developing embryo, with no effect on the pluripotency marker Nanog or the
trophectoderm marker Cdx2, however it reduced the deposition of the histone variant
H3.3 (Zhang et al., 2016). The NURD complex consists of CHD3 or CHD4 which is the
core ATPase subunit, MTA1, 2 or 3 (Metastasis Associated), MBD2 or 3 (Methyl-CpG
Binding Domain), and RbBP4 or 7 (Retinoblastoma Associated Binding Protein). During
the assembly of the NURD complex different combination of these mutually exclusive
subunits are assembled in different cell types (Qin et al., 2001). MBD3, a NURD subunit
that is required for complex assembly, knock-out resulted in post-implantation lethality
due to a defective maturation of the ICM into epiblast, and dis-organization of the
embryonic and extra-embryonic tissues (Kanji et al., 2007). CHD7 is the most studied
member of this family since the human CHD7 mutations result in CHARGE syndrome,
which is characterized by severe retardation in growth and development, heart defects,
coloboma of the eye (abnormal structure of the eye) and ear abnormalities. Some of
these features are recapitulated in mice with heterozygous loss of CHD7 (Hurd et al.,
2007).
1.3.4 INO80 Family
The INO80 family include the INO80 and SWRI complexes that contain the
INO80 ATPase subunit. The SWR1 and its homologue in mammals, Tip60/p400, is
required to deposit the histone variant H2AZ in vivo. H2AZ incorporation is crucial for
lineage commitment during mESCs differentiation (Creyghton et al., 2008). The INO80
complex is first identified in yeast where it regulates inositol responsive gene expression
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(Ebbert et al., 1999). The INO80 subfamily complexes are known to directly regulate
gene expression in yeast (Shen et al., 2000 and Korbor et al., 2004), mammals (Cai et
al., 2007), flies (Klymenko et al., 2006) and plants (Deal et al., 2007 and Fritsch et al.,
2004).
1.4 The INO80 Complex
The purified INO80 complex is approximately 1.2 MDa in mass and contains 15
subunits, which include the core catalytic ATPase INO80 subunit, RuvB-like (RuvBL1 or
RuvBL2), actin (β-Actin) and actin-related proteins (ARP5, ARP8 and BAF53A) (Shen et
al., 2000). The RvuBL1-2 subunits are homologous to the yeast Rvb1-2 subunits and
functionally similar to the bacterial DNA helicase RuvB which is involved in DNA DSB
(double-strand break) repair (Holliday et al., 1974). The actin and ARP (actin-related
proteins) are required for the INO80 remodeling activity where they bind the HSA
(helicase-SANT-associated domain) in the ATPase domain (Szerlong et al., 2008).
Other subunits that are involved in the regulation of specific process, such as YY1
subunit, which recruits INO80 to target genes to activate their transcription (Cai et al.,
2007). The INO80 complex is involved in many nuclear processes such as DNA
replication, DNA repair, cell cycle checkpoint and DNA damage response. These
diverse functions are due to the function of its distinct subunits. The ATPase subunit of
INO80 is unique because of the presence of a spacer that splits the conserved ATPase
domain and the deletion of this spacer prevents the assembly of the complex (Yunhe et
al., 2007). The INO80 ATPase activity is stimulated in vitro in the presence of DNA or
nucleosomes and this activity enhances nucleosomes sliding or eviction in vivo that
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subsequently remodel chromatin structure to regulate access to DNA (Tsukuda et al.,
2005). The remodeling activity of INO80 can be modulated by various mechanisms.
One mechanism is the post-translation modification of the complex subunits. For
example, upon DNA damage the Ies4p subunit of the yeast INO80 complex is
phosphorylated by the kinases Tel1p and Mec1p (ATM and ATR in mammals),
regulators of DNA damage response. However, this modification does not affect the
complex localization to the DNA damage sites (Morrison et al., 2007). Small signaling
molecules also modulate the activity of INO80. For instance, the inositol polyphosphate
kinase Arg82p mediates the recruitment of INO80 to the promoters of phosphate
responsive genes Pho5 and Pho84 in yeast (Shen et al., 2003).
1.4.1 INO80 in DNA Damage and Replication
To maintain genomic stability, cells have to efficiently repair DNA breaks. NHEJ
(non-homologous end joining) and HR (homologous recombination) repair DNA DSBs
(Hoeijmakers et al., 2001). In order for repair proteins to get access to their target DNA,
chromatin around DNA breaks is remodeled. This remodeling could be accomplished by
histone modifications, exchange of histone variants and/or ATP-dependent chromatin
remodeling (Shen et al., 2003 and Loizou et al., 2006). Mouse INO80 is recruited to
DSBs sites where it is involved in 5’-3’ resection of DNA. It is also, required for the
loading of the repair protein 53BP1 (p53-binding protein 1). 53BP1 is a DNA damage
response factor that mediates the repair of DSBs (FitzGerald et al., 2009 and
Gospodinov et al., 2011). In addition, mouse INO80 is required for the removal of H2AZ
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from chromatin to facilitate HR of DSBs (Alatwi et al., 2015). The incorporation of H2AZ
at DSBs restricts strand resection and its depletion reduces the recruitment of
Ku70/Ku80 complexes to DSBs sites to promote DNA repair (Xu et al., 2012).
In mammals, DNA damage induces the phosphorylation of the C-terminal of
H2AX by ATM into γH2AX, which is crucial component of the DNA damage response.
Defects in H2AX phosphorylation alter the DNA damage checkpoint and drive genomic
instability. γH2AX serves as docking sites for DNA repair proteins, such as INO80
(Nakamura et al., 2004). The mouse INO80 subunit BAF53A (Brg1-Associated Factor
53a) is associated with γH2AX and upon deletion; it reduces ARP recruitment of INO80
to DNA damage sites (Downs et al., 2004 and Morrison et al., 2004). In addition, the
association of γH2AX and INO80 complex at DSB is required for nucleosome eviction
around the DSB, which facilitates the binding and retention of repair proteins (Wu et al.,
2007 and Morrison et al., 2007).
The yeast INO80 subunits Nh10p (non-histone protein 10), Arp4p (actin related
protein) and Ise3p (Ino80 subunit) have unique roles in association with γH2AX to
facilitate DNA repair. Mutations in the yeast Arp subunit of INO80 complex results in
defective DSB repair through homologous recombination or non-homologous end
joining pathways, which further support its importance in these pathways (Kawashima et
al., 2007). In response to DNA damage, checkpoint pathways delay the cell cycle until
DNA is repaired.
In yeast, Mec1p is a DNA damage checkpoint kinase that activates downstream
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kinases to arrest the cell cycle, the INO80 subunit Ise4p is one of the Mec1p targets.
Phosphorylation of Ise4p activates the S-phase checkpoint and delays replication origin
firing until DNA repair is complete. Once complete then the S-phase checkpoint factor
Tof1p promotes replication fork recovery to resume the cell cycle (Kattou et al., 2003
and Tourrie et al., 2005). Similarly, when the replication fork collapses due to DNA
lesions or due to low levels of nucleotides, Ise4p subunit is phosphorylated to activate
the S-phase checkpoint to delay the cell cycle progression. Recent studies in yeast
showed that INO80 is enriched at replication origin, and higher levels of enrichment are
found at stalled forks, suggesting its role in the recovery of stalled forks during DNA
replication (Shimada et al., 2008, Papamichos-Chronakis et al., 2008 and Vincent et al.,
2008).
1.4.2 INO80 and Telomeres, Centromeres and Chromosomes
Telomeres are repetitive DNA sequences at the end of the chromosomes, which
decrease in length at each cycle of replication. Telomeres prevent the recognition of
chromosome ends as a DSB by DNA repair machinery (d'Adda et al., 2004). The mouse
INO80 is required for proper telomere replication where it prevents the formation of
fragile telomeres. In addition, mouse INO80 prevents aberrant recombination between
telomeres during their replication to prevent the activation of DNA damage response
(Min et al., 2013).
INO80 is required to regulate telomere structure and function. It has been
reported that deletion of Ies3p, Arp8p and Nhp10p subunits of yeast INO80 increased
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telomere length indicating their roles in the regulation of telomere structure. In addition,
the Ies3p subunit deletion induced telomere-telomere fusion events and reduced the
cells’ growth rate (Yu et al., 2007). During cell division, proper segregation of
chromosomes is crucial to ensure faithful transmission of genetic material. INO80 has a
role in chromosome segregation in yeast. The Arp4p and ATPase subunits of Ino80p
bind directly to centromeres, and mutated Arp4p subunit results in defective kinetochore
complex formation, and arrest of cell cycle. In addition, deletion of the Arp8 subunit
increased the rate of sister chromatids separation (Ogiwara et al., 2007). Although the
exact mechanism of INO80 in the regulation of chromosome segregation is unknown, it
could be due to its ability to incorporate H2A histone variants into nucleosomes resulting
in specialized structures with defined roles in centromeres, telomeres, and
chromosomes.
1.5 Embryonic Stem Cells
Embryonic stem cells are pluripotent cells derived from the ICM before
implantation, and after implantation they differentiate into the three germ layers of
endoderm, mesoderm, and ectoderm. The expression of the core pluripotency genes,
Oct4 (encoded by POU5F1), Sox2 (high mobility group- box transcription factor), Nanog
(a homeobox transcription factor) and Esrrb are required for the maintenance of ESC
pluripotency (Nichols et al., 1998, Avillion et al., 2003, Mitsui et al., 2003, Chambers et
al., 2003 and Martello et al., 2012). The use of LIF (leukemia inhibitory factor) or BMP
(bone morphogenetic protein) can keep ESCs in a naïve state (metastable state) where
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they can self-renew. However, these growth conditions result in a heterogeneous
population of cells with mosaic expression of pluripotency factors (Ying et al., 2003).
Mechanistically, LIF binds the gp130 on the cell surface, activates STAT3 which then
homodimerizes, and translocates to the nucleus to activate the transcription of core
pluripotency genes (Graziano et al., 2013). BMP mediates its signaling through
phosphorylation of SMAD1, 5, 8 which in turn activates the transcription of Id (inhibitors
of differentiation) to block differentiation and keep cells pluripotent (Boyer et al., 2005).
Differentiation mESC results in the secretion of FGF4, which binds the FGF receptor on
ESC, acting as an autocrine, to activate the MAPK pathway driving differentiation
(Kunth et al., 2007 and Stavridis et al., 2007). Consequently, the key to maintaining a
homogenous population of pluripotent cells (the ground state) is to override the FGF4
differentiation signal and maintain the expression of core pluripotency genes at the
same time, which is achieved by the use of 2i. 2i blocks the ERK (extracellular regulated
kinase) to repress differentiation and Gsk3 (glycogen synthase kinase-3) pathways to
activate pluripotency genes (Ying et al., 2008). The ground state pluripotency mimics
the pluripotency state of ICM cells. Once LIF or 2i is removed from the media the ESCs
is reprogrammed to a primed state where the cells are similar to the late epiblast after
implantation (Nicholas and Smith, 2009).
The chromatin organization in mESC has a key role in the switch between
pluripotency and differentiation states. Pluripotent ESCs have loosely associated
chromatin architectural proteins such as linker histones and HP1 (heterochromatin

19

protein 1), which results in hyperdynamic chromatin. In addition, staining of the active
histone marks H3K4me3/ H4K16ac and in situ hybridization of satellite DNA revealed
less condensed constitutive heterochromatin in pluripotent ESCs (Park et al., 2004 and
Meshorer et al., 2006). In addition, genome-wide mapping of epigenetic modifications of
mouse ESCs indicated hypomethylated DNA in those cells (Meissner et al., 2008).
Although maintaining pluripotency requires an open chromatin state to transcribe
pluripotency genes, it also requires repression of differentiation genes to keep cells
pluripotent. The key developmental genes in mESCs are mostly bivalent, which means
that they have the active histone marker H3K4me3 and the repressive mark H3K27me3
at opposing H3 tails on the same nucleosome. The bivalency in these genes keeps
them in a poised state. Once the cells differentiate into a specific cell lineage, bivalent
genes become monovalent with either activating or repressive marks (Bernstein et al.,
2006).
During differentiation, mESCs acquire more condensed, compact and less
dynamic chromatin structure. Genome-wide analysis of the repressive histone
modification H3K9me2 identified enrichment of these marks at the facultative
heterochromatin (gene poor), which constitute 31% of genome in differentiated cells
compared to 4% in pluripotent ESCs (Wen et al., 2009). In addition, the repressive
histone mark, H3K27me3, expands into large domain during ESCs differentiation.
Collectively, ESCs have to repress pluripotency and lineage inappropriate genes and
activate lineage-specific genes with the help of chromatin modifiers to modulate the
chromatin architecture according to their needs. Consistently, ESCs express high levels
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of chromatin remodeling complexes such as BRG1, SNF2H, SSRP1 and SNF5, and
their disruption resulted in early embryonic lethality suggesting their essential role in
ESCs gene regulation (Bultman et al., 2000, Klochendler et al., 2000, Cao et al., 2003
and Stopka et al., 2003). INO80 is required for ESCs self-renewal (Chia et al., 2010; Hu
et al., 2009), possibly due to its direct role in the regulation of the core pluripotency
genes to maintain the ESC pluripotency state. In addition, INO80 occupies the
promoters of pluripotency genes to maintain open chromatin structure and nucleosome
depleted regions which facilitates the recruitment of RNA Pol II to initiate transcription
(Li et al., 2014)
1.6 Mouse Early Development
Mammalian development is a very complex process, which starts with a single
fertilized egg and gives rise to a whole embryo. Upon fertilization, the oocyte mRNA is
degraded and transcription is initiated from the zygote genome, which is required for
genetic reprogramming during development, a process known as ZGA (zygote genome
activation) (Nothias et al., 1995). It has been shown that there is a transient phase of
ZGA at 2-4 cell stage, which drives the transcription of reprograming genes and another
phase of maternal genome activation at the 8 cell stage where a peak in transcription of
adhesion molecules that is required for blastocyst polarity (Hamatani et al., 2004). After
fertilization, the developmental stages of mouse embryo are determined by the embryo
age. Embryos are staged by half-day intervals after the detection of a copulation plug,
and is referred to as E (embryonic day) (Kojima et al., 2014). The fertilized egg
undergoes three rounds of cell division to reach the eight-cell stage in which the embryo
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is composed of four blastomeres. At the 8-cell stage, the nucleo-cytoplasmic ratio is
increased, which induces these blastomeres to compact into a morula. During
compaction, cells maximize their contact using tight junctions to form a compact ball of
cells. Compacted cells form a gap junction to allow the passage of small molecules and
ions for their nutrition (Fleming et al., 1992, Ducibella et al., 1975 and ziomek et al.,
1980). Compaction establishes apical-basal polarity in the morula by asymmetrical
loading the cellular polarity proteins such as PKC (protein kinase C), PAR3 and PAR6
(Pauken and Capco, 2000; Plusa et al., 2005) to the apical cells of the morula. However
proteins such as Par1 (protease activator receptor 1) and E-cadherin (Hyafil et al.,
1980; Shirayoshi et al., 2005) localize to the basolateral side of the morula by E2.5.
Compacted morula undergoes two successive rounds of asymmetric cell division to
form 16-32 blastocyst embryo.
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Figure 1.2: Cartoon to Illustrate Stages in the Early Mouse Development.
The morphological changes and the cell specification events that occur from fertilization to embryonic day
E7.0. The morula stage at E2.5, the blastocyst stage at E3.5, and the gastrula stage at E6.5. The pregastrula stage starts at E5.5 where a subset of PrE cells differentiate at the distal part of the embryo to
form DVE. From E5.5 to E6.5 these cells migrate to the anterior part of the embryo to form AVE. During
this transition the AVE secretes inhibitors to the Wnt and TGF family of ligands, directing gastrulation at
the posterior of the embryo. http://www.devbio.biology.gatech.edu/?page_id=8796.
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A blastocyst is formed at E3.5 by cavitation; formation of a single cavity; and
allocation of three cell lineages which include TrE (trophectoderm), PrE (primitive
endoderm) and EPI (epiblast) as illustrated in Figure 1.2. TrE is the outer layer of cells
that contact the LE (luminal epithelium) of the uterus to establish the site of
implantation. TrE will form the chorion (abembryonic tissue), which is required for
embryo nutrition and immunity at implantation site (Pedersen et al., 1987). The ICM is
composed of pluripotent cells that will form the embryo proper (embryonic tissue). The
segregation between these three different cell lineages (TrE, PrE and EPI) is defined by
the expression of specific genes for each lineage. Oct4, Sox2, Nanog and Nodal genes
are required for the formation and maintenance of the ICM, suppression of TrE
formation and specification (Nichols et al., 1998, Avillion et al., 2003, Mitsui et al., 2003,
Chambers et al., 2003 and Camus et al., 2006). TrE specification was thought to be due
to the absence of Oct4 expression, however Strumpf et al. showed that the Cdx2 (a
caudal type-homeodomain protein) is essential for TrE specification and its absence
extends the expression domain of Oct4 and Nanog into the outer layer (Strumpf et al.,
2005). In addition, the T-box transcription factor, Eomes, is required for TrE cells
proliferation (Russ et al., 2000). Similarly, PrE is specified by the expression of Gata6,
which suppress the expression of Nanog (Mitsui et al., 2003 and Chambers et al.,
2003).
In addition, epigenetic changes like histone modifications are key players in the
molecular definition of these cell fates. For example, the levels of active histone
markers, H4K8ac and H3K4me3, at the promoter region of Oct3/4 are higher in the
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ICM cells than in the TrE cells (VerMilyea et al., 2009). The behavior of these factors
inside the cell also affect those cells fate. Monitoring the kinetics of Oct3/4 nuclear
export, import and retentions revealed that Oct3/4 accessibility to its targets differ
between four- and eight- cell stage (Plachta et al., 2011).
The embryonic-abembryonic axis specification is similar to the P-D (proximaldistal) axis of the embryo at the egg cylinder stage, which will determine the future
dorsal-ventral polarity (Rossant and Tam, 2009). In addition, the inside-outside polarity
of the blastocyst is also accompanied by differential asymmetric signaling of Hippo
pathway in those parts of the blastocyst. Hippo signaling control cell contact-mediated
inhibition of ICM proliferation. However, it is not active in the outer cell layer where the
apical part of these cells is not in contact with other cells (Pan, 2007; Saucedo and
Edgar, 2007). The peri-implantation blastocyst exhibits additional asymmetries, for
example, the nuclear β-catenin is localized to a subset of blastomeres and Nodal is
localized to another subset suggesting asymmetry at the level of canonical Wnt and
Nodal signaling (Chazaud et al., 2006 and Granier et al., 2011).
In order for the blastocyst to implant, it has to be competent for implantation in
the receptive uterus. Many factors affect blastocyst competency, for instance, catecholoestrogens, endocannabinoid and anandamide are signaling molecules secreted in
the uterus to activate the blastocyst (Paria et al., 1998 and Guo et al., 2005). The
implantation process is divided into three stages; apposition, adhesion and penetration.
Apposition, where TrE of the blastocyst closely oppose the LE of the uterus to prevent
blastocyst dislodging (Daikoku et al., 2005). Once the blastocyst opposes the LE it
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attaches by help of adhesion molecules such as integrin (Dey et al., 2004). After the
blastocyst attaches, penetration occurs at the site of implantation to increase the
vascular permeability by the action of prostaglandin (Lim et al., 1997). After
implantation, the stromal cells of the uterus that envelop the blastocyst undergo
decasualization to nourish the embryo and form the placenta, which is accompanied by
increased angiogenesis (Matsumoto et al., 2002). Once the blastocyst is implanted, it
develops into a cylindrical structure called the egg cylinder, which will undergo
gastrulation (Patrick et al., 1997).
1.7 Gastrulation
Gastrulation is a blueprint for body plan determination and subsequent
morphogenesis. Immediately after implantation (approximately at E5-6), the embryo
mass is increased by about 40 fold mainly due to increased cell proliferation and
reduced apoptosis rates. At this stage, an epithelization of ICM cells into a single cell
layer surrounding the amniotic cavity forming a cup-shaped embryo (in the case of
rodents), where the cup has two cell layers, the outer VE (visceral endoderm) and inner
Epi (epiblast), forming an egg cylinder with two cell layers. The egg cylinder embryo has
well defined extra-embryonic and embryonic regions that are polarized to P-D body
axis. During gastrulation, a series of morphogenetic movements results in the formation
of three germ layers: ectoderm, endoderm and mesoderm. The mouse gastrulation is
accomplished by the differentiation, delamination, and migration of underlying
embryonic ectoderm into the primitive streak to establish the A-P (anterior-posterior)
axis of the embryo (Patrick et al., 1997).
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As mentioned earlier PrE is the epithelial layer that surrounds the blastocoelic
cavity. At E5.5, this layer forms the VE that surrounds the epiblast and parietal VE that
surround the TrE. A subset of distal VE cells differentiates into DVE at E5.5 (Rossant
and Tam, 2009; Takaoka and Hamada, 2012). DVE cells express both Nodal and Wnt
antagonists, which are Lefty1, Cer1 and Dkk1 consequently (Yamamoto et al., 2004 and
Kimura-modisha et al., 2005). Restriction of Lefty1 expression to a subset of PrE cells
could be regulated by three mechanisms: (1) Lefty1 is regulated directly by Nodal
through Nodal/FoxH1 responsive enhancer upstream of Lefty1. (2) Nuclear β-catenin is
localized to Epi cells that face PrE suggesting that Wnt signaling activates Nodal which
in turn regulate Lefty1 expression (Chazaud and Rossant 2006). (3) Establishment of PD axis is maintained by asymmetric expression of signaling molecules and asymmetric
expression of Nodal restricts Lefty1 expression to a subset of PrE cells (Granier et al.,
2011).
From E4.5 to E5.5 the expression of Lefty1 is auto-regulated by Lefty1 itself
(Christopher et al., 2001). At E5.5, DVE cells mature and express other DVE markers
such as Cer1 and Hex1. The restriction of DVE cells to the distal part of the embryo is
maintained by inhibitory BMP signaling. Bmp4 expression in the extraembryonic
ectoderm generates a signaling gradient that allows DVE differentiation only at the distal
part of the egg cylinder. This was further supported by the observation that ExE deletion
resulted in DVE expansion (Roriguez et al., 2005 and Yamamoto et al., 2009). After the
DVE matures, the VE cells get thicker and create a monolayer of tall-columnar cells
(Takaoko et al., 2011), then DVE cells form a lamellopodia-filopodia like structure that
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migrates to the anterior part of the embryo to establish the AVE and the A-P axis
(Migeotte et al., 2010).
How the complicated process of animal embryonic development is regulated by
epigenetics is just beginning to be unraveled. ATP-dependent chromatin remodeling
complexes are essential for mammalian development where they regulate specific
developmental pathways (Ho et al., 2010 and Chen et al., 2014). The chromatin
remodeling complexes, NURD (Kaji et al., 2007), SWI/SNF (Bultman et al., 2000), and
TIP60/p400 (Thomas et al., 2008) complexes are essential for pre-implantation
development. While, other complexes including NURF (Landry et al., 2008) and CHD7
(Hurd et al., 2007) are involved in post-implantation development. Mammalian INO80 is
also essential for development. Genome-wide siRNA screening show that Ino80 is
required for ESC self-renewal by promoting the expression of pluripotency genes such
as Oct4 and maintaining an open chromatin structure around pluripotency factors (Li et
al., 2014). In vivo, Ino80 KO mouse embryos implant but fail to develop to mid-gestation
(Min et al., 2013), possibly due to abnormal gene expression because INO80 is wellknown to regulate gene expression (Li et al., 2014). However, the exact mechanism by
which INO80 regulates early mouse development is unknown. The purpose of this study
is to characterize the role of the INO80 chromatin-remodeling factor in early mouse
embryo, and identify the mechanisms by which it regulates development.
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CHAPTER TWO
Methods

2.1 Generation of Conditional Ino80 KO Mice.
This was done according to the standard protocol. The Animal Care and Use
Committee of Virginia Commonwealth University approved all experiments and animal
procedures under protocol AD10000372 and its modifications (Bouabe et al., 2013).
2.2 DNA Extraction & Genotyping
DNA was extracted from embryos for genotyping by digesting individual embryos
overnight at 55°C in 10 to 20 µl PBS (phosphate-buffered saline) (10 mM Na2HPO4,
and 1.8 mM KH2PO4 [pH 7.4], 137 mM NaCl, 1.37 mM KCl), 0.1% tween 20 and 0.2
mg/ml PCR grade proteinase K (Roche). After digestion, proteinase K was heat
inactivated at 100 °C for 15 min and 2 µl of digested embryo was used for PCR
genotyping. Genomic DNA was extracted from tail biopsies or cells by overnight
digestion in lysis buffer (50 mM Tris-Cl [pH 8.0], 100 mM EDTA, 100 mM NaCl and 1%
SDS) containing proteinase K (0.5 mg/mL) at 53 °C. Following digestion, DNA was
precipitated with isopropanol, washed with 70% ethanol and dissolved in water. The
genotyping of Ino80 was done using primers P1, P2, and P3 in a multiplex PCR reaction
using recombinant Taq polymerase with Thermal Pol Buffer (NEB). PCR conditions
were as follows: 94 °C for three minutes (min) for one cycle, 94 °C for 30 secs, 54 °C for
60 secs, 72 °C for 45 sec repeated for 40 cycles. Primer sequences are provided in
Table 2.
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Table 2.1: Primers Used for Ino80 Genotyping
Ino80 Genotyping Primers
P1
P2
P3

CTGGATGTGAAGGGAGAAGG
CATCTCTCCAGCCAGCACACT
TGCCACTCTACCTGCATCTG

2.3 Embryonic Cells Isolation and Maintenance
To generate Ino80 KO ESCs, E2.5-day blastocysts were harvested in KSOM
media until the blastocyst stage then induced to hatch in the presence of Tyrodes
solution (Sigma T1788). Blastocysts were cultured on gelatinized plates for seven days
in defined 2i + LIF media without serum (Millipore Cat# SF016-100). Individual
outgrowths were removed by scratching from plate bottom with a fine glass pipette,
dispersed into single cells with 0.25 % trypsin + EDTA, cultured in gelatinized 96 well
plates in the presence of 15 % ESC grade FCS (Life Technologies) and 2i medium
formulation (Life Technologies).
Primary MEFs were isolated from mouse pregnant females at E13-14. Mouse
female was sacrificed by cervical dislocation and individual embryos were isolated from
the uterine horns under aseptic conditions. Head and internal organs were removed and
the embryo body was finely minced until it can be pipetted. Digested embryo was
treated with 0.25% trypsin/EDTA in the presence of 100 K units of DNase I (USB) for 15
min at 37°C to obtain single cell suspension. Trypsin was inactivated by MEF culture
medium (DMEM containing 10% FCS, 2 mM glutamine, 1 mM nonessential amino
acids, penicillin, and streptomycin). Cells were then centrifuged, suspended in MEF
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culture medium and plated on gelatinized plates. MEFs were treated with 10 ng/ml
doxycycline in MEF culture
medium to knock-out Ino80. After two days of treatment, the medium was replaced with
fresh medium and MEFs were cultured until subconfluency. Ino80 deletion was verified
by PCR.
2.4 Detection of MEFs Senescence by Lac-Z Staining
To measure β-galactosidase activity, MEFs were fixed in 4% buffered
formaldehyde for five min, washed and stained with staining solution (35 mM
potassium ferrocyanide, 35 mM potassium ferricyanide, 0.02% NP-40 and 2 mM MgCl2
[pH 6]) overnight with gentle rocking. Stained cells were washed and positively stained
cells were counted using a microscope.
2.5 Alkaline Phosphatase Staining
AP activity was analyzed using the BM purple AP substrate (Roche Cat#
11442074001), according to the manufacturer’s guidelines. Cell colonies were fixed
in 0.2% glutaraldehyde, 0.02% NP-40, and 0.01% sodium DOC for five min followed by
washing in 100 mM Tris-HCl [pH 9.5], 100 mM NaCl and 10 mM MgCl2. Colonies were
stained, washed, air dried and examined under light microscope.
2.6 Cell Doubling Time
To determine the doubling time, mESCs were plated in triplicates in 12 well
plates. Cells were counted using a hemocytometer at time points 24, 48, 72, and 96
hours. I took the average cell count from each of the big four squares. and multiply by
10,000 then multiply by 2 to correct for trypan blue addition Population doubling times
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were calculated using http://www.doubling-time.com.These measurements were
repeated for three independent control and Ino80 KO mESCs.
2.7 Teratoma and Embryoid Body Formation
Teratomas was generated by injection of 1 × 106 ESC into the flank of
NOD/SCID mice (Jackson Labs Cat# 001303). Three weeks later teratomas were
collected, embedded in OCT medium and frozen in liquid nitrogen. Teratomas were
sectioned using a cryostat and sections were fixed in 10% neutral buffered formalin,
stained with hematoxylin and eosin, and analyzed by light microscopy.
To create embryoid bodies 10 × 106 ESC were suspended in 13 × 100 mm
polypropylene culture tubes. The cells were supplemented with 3 ml of complete ESC
medium without addition of LIF or 2i to promote cells differentiation. Embryoid bodies
were harvested at the indicated time points. For histological analysis, embryoid bodies
were collected at day 9 and fixed in 10% neutral buffered formalin overnight, then
embedded in OCT medium and frozen in liquid nitrogen. Sections were obtained by
cryostat sectioning, stained with hematoxylin and eosin, and analyzed by light
microscopy.
2.8 Whole Mount in Situ Hybridization
Embryos were collected at the indicated time points in PBS, fixed in 4%
paraformaldehyde for 5 min. Fixed embryos were then dehydrated through a series
of methanol (25%, 50%, 75%, and twice in 100%) and kept in 100% in methanol at
−20°C until use. To prepare embryos for in situ hybridization they were rehydrated
through 75%, 50%, and 25% methanol series then fixed again in 4% and 0.2%
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glutaraldehyde in PBS-T (Phosphate-buffered saline 0.1% tween 20). To start
hybridization, embryos were washed three times in PBS-T and mixed with prehybridization buffer (25ml formamide, 12.5 ml 20X SSC, 5ml 10% SDS and 7.3ml
DEPC treated water) at 70°C for 1 hr. Hybridization buffer was then replaced with
one ml of the same buffer mixed with ~ 1µg of DIG (Digoxigenin)-labeled probe and
then incubated overnight at 70°C. Embryos were washed twice for 30 min using
solution I (50% formamide, 4XSSC and 1% SDS) followed by 10 min wash in 1:1
solution I: solution II (500 mM NaCl, 10 mM Tris [pH 7.5] and 0.1% tween 20).
Embryos were then washed three times 5 min each in solution ll at room
temperature and incubated with solution II mixed with 100 µg/ml RNase at 37°C for
1 hr followed by one wash in solution ll and another wash in solution lll (50%
formamide and 2XSSC). Embryos were then washed twice for 30 min each with
solution lll at room temperature. Then washed three times for 5 min each with
MABTL (100 mM maleic acid [pH 7.5], 150 mM NaCl, and 0.1 % tween 20 and 2
mM levamisole). To prevent non-specific staining embryos were incubated with 10%
heat-inactivated sheep serum, 2% BMBR (Boehringer Mannheim Blocking Reagent)
in MABT for 3 hrs. During the incubation period, anti-digoxygenin-AP (Roche) was
mixed with 3 mg embryo powder, 2% BMBR and 10 µl of sheep serum in 1 ml of
MABTL and rotated at 4°C for 3 hrs. Embryos were then incubated with the diluted
antibody at 4°C overnight. Embryos were then washed for 5-8 times 1 hr each with
MABTL and the color was developed with BM purple (Roche) after three washes
with NTMTL buffer (100 mM Tris, [pH 9.5], 100 mM NaCl, 50 mM MgCl2, 0.1 %
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tween 20 and 2 mM levamisole). For double ISH DIG-Bmp4 and FITC-Otx2, labeled
probes were detected by AP-conjugated anti-DIG Fab, which was detected by BM
purple (Roche) and anti-FITC Fab fragment, which is detected by INT/BCIP (Roche),
subsequently.
2.9 TUNEL Assay
Programmed cell death is characterized by DNA fragmentation, which can be
quantified by the ability of the terminal deoxynucleotidyl transferase enzyme to
incorporate labeled nucleotides to the 3’ hydroxyl of fragmented DNA. To quantify
apoptosis, we applied whole-mount tunnel staining procedure. Briefly, E6.5 embryos
were fixed for 2 hrs at 4°C, washed with PBS-T and kept in 100% a methanol until use.
Fixed embryos were then treated with 5:1 methanol: 30% hydrogen peroxide for three
hours to reduce endogenous peroxidase activity. Then, they were washed in a methanol
and treated with 20 µg/µl proteinase K for 3 min to digest proteins and facilitate the
enzymatic addition of labeled nucleotides. After proteinase K treatment, embryos were
fixed with 0.2% glutaraldehyde in 4% paraformaldehyde for 20 min at room
temperature, washed three times with PBS-T and treated with sodium borohydride for
20 min to remove reactive aldehydes. Embryos were then washed with TdT buffer (30
mM Tris-HCl [pH 6.6], 200 mM potassium cacodylate, and 2.5 mM CoCl2). TdT buffer
was replaced with labeling solution that contain 9:1: labeling solution (nucleotide
mixture): enzyme (terminal deoxynucleotidyl transferase) and incubated at 37°C for 2
hrs. Then embryos were rinsed several times with PBST and incubated at 70°C with the
labeling solution for another 20 min. To block non-specific binding, embryos were
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treated with 10% heat- inactivated sheep serum at room temperature for 1 hr and then
incubated with the converter-POD (anti-fluorescein antibody, Fab fragment from sheep,
conjugated with horseradish peroxidase) at 37°C for 30 min followed by washing and
color development using the DAB substrate. Samples were analyzed using fluorescent
microscope and percent of apoptotic cells were normalized to the total number of DAPI
positive nuclei in a 50-µm microscopic field.
2.10 Chromatin Immunoprecipitation (ChIP)
mESCs cells were induced to differentiate by culture in complete ESCs medium
that lack both LIF and 2i. Cells were collected at the indicated time points and fixed in
1% PFA in PBS for 15 min. To remove the fixative, cells were washed three times in
PBS and scrapped from the tissue culture dish by a cell scraper. Cells were suspended
in lysis buffer and protease inhibitor and the chromatin was fragmented by sonication,
using Bioruptor sonicator set at 15% amplitude for three sessions of 45 pulses (0.5
second on/0.5 second off), incubating the sample on ice for two min between sessions
to fragment DNA to ~ 500bp fragments. After sonication, the cell suspension was
centrifuged at 13,000 rpm for 10-20 min at 4°C. The supernatant was diluted at 5:1 by
ChIP dilution buffer (16.7 mM Tris-HCl [pH 8.1], 167 mM NaCl, 1.1% triton X-100, 1.2
mM EDTA and 1 X protease inhibitor cocktail (Roche) then mixed overnight at 4°C with
protein G Dynal beads (Life Technologies) pre-bound for 1 hr at 4°C with antibody (10 μl
of beads with 5 μg antibody). For each pull-down, 20% input was saved for
determination of pull-down efficiency using qPCR. The following antibodies were used
for ChIP: Ino80 (VCU23, custom rabbit polyclonal), SP1 (Santa Cruz Biotech # sc-59),
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pan-histone H3 (Abcam # ab1791), and H3K4me3 (Abcam # ab1012) and anti-BPTF
(Millipore ABE1966). After overnight incubation, bound chromatin was subjected to a
series of 5 washes (5 min each) on ice using the following buffers; low-salt buffer (20
mM Tris [pH 8.0], 150 mM NaCl, 1% triton X-100, and 2 mM EDTA), high-salt buffer (20
mM Tris [pH 8.0], 500 mM NaCl, 1% triton X-100, and 2 mM EDTA), LiCl buffer (10 mM
Tris [pH 8.0], 0.25 M LiCl, 1% NP-40, 1% deoxycholic acid, and 1 mM EDTA) and two
times with TE buffer (10 mM Tris [pH 8.0], 1 mM EDTA). The DNA was eluted from the
beads by two washes with 250 µl elution buffer (0.1 M NaHCO3, and 1% SDS) at room
temperature. Both eluted DNA and the 20% input DNA were reverse cross-linked with
200 mM NaCl and incubated overnight at 65°C. Next, samples were treated with
proteinase K for 4 hrs at 45°C. The DNA was extracted using phenol-chloroform
extraction, precipitated with ethanol and dissolved in water treated with RNase A and
then quantified by qRT-PCR. The sequence for primers used for ChIP-PCR are
provided in Table 2.2
Table 2.2: Primers Used for Bmp4 ChIP Analysis
Bmp4 ChIP Primers
Amplicon1
Amplicon2
Amplicon3
Amplicon4
Amplicon5
Amplicon6

For GTGCCCAAAGCATTTTGAAT
Rev CACCCTACTTCCACCTCCAA
For CCAGTGCTCTCTCACCTTCC
Rev CAGGGGAGGTCACGAAGATA
For TACAAACGAGGATGGGGAAG
Rev CCAAGAACCGGAAATTGCTA
For CCCAATGACCTCTCTTCCAA
Rev TTGGCCTATTCCTCCTTCCT
For ATGGCATGGTTGGTTGAGTT
Rev ACGTAGTCCCAAGCATCACC
For ATGACCGGGTTGAAAGATTG
Rev GAAAGCCACACCTCCTTCTG
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2.11 Formaldehyde-Assisted Isolation of Regulatory Elements (FAIRE)
Positive regulatory factors enhance nucleosomes eviction at their target DNA
sequences. The idea of the FAIRE technique is to identify nucleosome-depleted DNA
sequences (open chromatin). FAIRE is a simple technique to identify nucleosomes
depleted DNA sequences and it is superior to DNase I hypersensitivity assay. The idea
behind FAIRE technology is the crosslinking of proteins to DNA, fragmentation of the
chromatin and enrichment of nucleosome depleted DNA sequences by phenolchloroform extraction. To identify the chromatin status at Bmp4 promoter in both WT
and Ino80 KO cells we applied the FAIRE technique. Briefly, cells were fixed in 1%
paraformaldehyde and resuspended in FAIRE lysis buffer (50 mM Tris [pH 8.0], 1%
SDS, 10 mM EDTA). Protein degradation was inhibited by addition of 1X protease
inhibitor cocktail (Roche) to the lysis buffer. Samples were sonicated as indicated above
and sonicated samples were centrifuged at 15,000 rpm at 4°C to remove cell debris. An
equal volume of supernatant and phenol-chloroform were mixed, vortexed and
centrifuged at 15,000 rpm to isolate FAIRE DNA in the aqueous phase. FAIRE DNA
was ethanol precipitated in the presence of 0.3M sodium acetate and dissolved in TE
buffer (10 mM Tris-HCl [pH 7.4], 0.5 mM EDTA). Dissolved DNA was treated with
RNase at 100 µg/ml for 30 min at 37°C followed by proteinase K treatment at 55°C for 1
hr. After removal of residual RNA and proteins, FAIRE DNA was washed, mixed with
DNA binding buffer at 2:1 ratio then purified using Zymo-I spin columns (Zymo
research). The input DNA was prepared from the soluble chromatin after sonication
where 50 µl of soluble chromatin was treated with RNase and proteinase K, as
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described above, and cross-linked between DNA molecules was reversed by keeping
samples at 65°C overnight. DNA was extracted by phenol-chloroform extraction
followed by ethanol precipitation. Enrichment of individual loci was quantified by qRTPCR. Primers were designed to amplify a control region that has similar enrichment in
both WT and Ino80 KO samples and a reference region that has different enrichment.
Relative enrichment was quantified and calculated using the ∆∆CT method (Livak et al.,
2001). Primer sequences are provided in Table 2.3.
Table 2.3: Primers Used for FAIRE Analysis
Bmp4 promoter FAIRE Primers
Amplicon1
Amplicon 2
Amplicon 3
Amplicon 4
Amplicon 5
Control Primers

For CTTCCCTCCTCCCTTAATCG
Rev1 GTGGCTGGATGGGAGGAT
For1 GTTGAAACAGGCTGTGAGCA
Rev1 GGGGGAAAGTCACCTCCTAA
For1 AATTTCACACCCTGCCTCTG
Rev1 TTCCCCATCCTCGTTTGTAA
For1 GATTGATTCCCTGCGTCACT
Rev1 TCAGTCATTTTCGGTCTGG
For1 CAGGTAGAGTGGTGCATGCTT
Rev1 GATCATCTGGCTGCCTCTGT
For1 ATACAACCAAACAGACACACAACC
Rev2 CTACTGGCTGCCATGGCTTA

2.12 qRT- PCR
RNA was extracted from ESCs and embryoid bodies using Tri-Reagent (Sigma)
according to manufacturer’s instructions. 5 µg of isolated RNA was converted into cDNA
using the reverse transcriptase Superscript II according to manufactures procedures
(Life Technologies). cDNA was diluted and amplified using SsoAdvanced universal
SYBR green supermix (Biorad) in 20 µl reaction that contains 300 nM of both forward
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and reverse primers. Reactions were heated for 15 min at 95 °C, then cycled for 50
cycles at 95 °C, 30 secs, 60 °C 30 secs and 72°C 30 sec. Relative expression of target
templates was normalized to GAPDH using the ∆∆CT method (Livak et al., 2001).
Primers sequences are provided in Table 2.4.
Table 2.4: Primers Used for Quantification of Pluripotency and Differentiation
Markers in mESCs
qRT‐PCR Primers
INO80
Nanog
Oct4
Klf4
Essrb
Sox2
c-myc
n-myc
Cdx2
Bmp4
Fgf5
Nestin
Nodal
T
Wnt3
Gsc

For CGAGGGAGCGAGCTAGGAG
Rev TCAACTTGGCTTTAAGCTTCTTG
For AGGGTCTGCTACTGAGATGCTCTG
Rev CAACCACTGGTTTTTCTGCCACCG
For TGAGGCTACAGGACACCTTTC
Rev GTGCCAAAGTGGGGACCT
For GCGAGTCTGACATGGCTGT
Rev GAGTTCCTCACGCCAACG
For CGATTCATGAAATGCCTCAA
Rev CCTCCTCGAACTCGGTCA
For TGCTGCCTCTTTAAGACTAGGG
Rev TCGGGCTCCAAACTTCTCT
For CACCAGCAGCGACTCTGAA
Rev CCCGACTCCGACCTCTTG
For AACACAGCGCTTGAGGATCA
Rev GAGCGACTCAGATGATGAGGA
For GGAAGCCAAGTGAAAACCAG
Rev CTTGGCTCTGCGGTTCTG
For CTGAGTATCTGGTCTCCGTCC
Rev AAGGCTCAGAGAAGCTGCGGC
For CAGATCTACCCGGATGGCAAAG
Rev GCGGACGCATAGGTATTATAGCTG
For ACCTCAAGATGTCCCTTAGTCTGG
Rev GGTGCTGGTCCTCTGGTATCC
For GGGCCCACTCACCATTGACA
Rev TCCTGAGGCCGGTTGGAGTA
For TGAGGAGATTACAGCCCTTAAA
Rev GGTTCCTTAGAGCTGGGTAC
For GGGGCGTATTCAAGTAGCTG
Rev GTAGGGACCTCCCATTGGAT
For CGGTTCTGTACTGGTGTCTCCT
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Fgf8
Foxa2
Sox17
Gata4
Gata6
Hex1
Cer1
Hnf4a

Rev GAGCTGCTCATCGGTCAAGAT
For TCATTGTGGAGACCGATACTT
Rev CAGCACGATCTCTGTGAATAC
For GCCAGCGAGTTAAAGTATGCG
Rev TGTTGCTCACGGAAGAGTAG
For CCATTTAGTGAAGAAACTGAAATATGGC
Rev ATTCTCTTGATAGATACTTTGGGAGGAGT
For AGGTAGTGTCCCGTCCCATCT
Rev CCTGGAAGACACCCCAATCTC
For AGTCAAAAGCTTGCTCCGGTA
Rev ACCTATGTAGAGGCCGTCTTGA
For GAGGTTCTCCAACGACCAGA
Rev GTCCAACGCATCCTTTTTGT
For CACGAAGTACACTGGGAGAC
Rev GCCAAAGCAAAGGTTGTTCT
For CTTCCTTCTTCATGCCAG
Rev ACACGTCCCCATCTGAAG

2.13 Statistics
The standard deviation was used to calculate error bars throughout the study. P
values were calculated using two tailed T-tests. The number of replicates are
designated in the figure legends.
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CHAPTER THREE
Results
3.1 Ino80 KO Embryos Fail to Develop After Implantation
Ino80 deletion is known to be embryonically lethal (Min et al., 2013 and Lee et
al., 2014), however, its exact role in early mouse development is not identified. To
investigate the role of Ino80 in mouse early embryo, we used the Cre-loxP system in
which the essential exons of Ino80 were flanked by two loxP sites that were excised
after crossing with mice that express Cre recombinase. Successful Ino80 KO was
verified in both Ino80 KO MEFs using Western blot analysis (Figure 3.1 A). At the
cellular level, Ino80 KO in MEFs reduces cell proliferation and induces senescence (Min
et al., 2014). To verify this observation using our model of Ino80 KO in MEFs, we
assessed the proliferation rate of Ino80 floxed MEFs for about 12 days after their
exposure to doxycycline in culture (Figure 3.1 B). As shown previously, Ino80 KO MEFs
ceased proliferation and started senescence as evidenced by their positive staining for
β-Gal activity (Figure 3.1 C). These data suggested that our Ino80 KO allele is a null
allele.
To characterize the phenotypes of Ino80 KO in mouse embryo we inter-crossed
heterozygous mice to generate homozygous Ino80 KO mice. However, we did not get
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any homozygous KO mice, consistent with previous studies that showed that Ino80 is
essential for mouse embryo viability (Min et al., 2013 and Lee et al., 2014). To identify
at which stage Ino80 is essential for embryo viability, we collected mouse embryos at
different stages of early development E5.5 (post-implantation), E6.5 (gastrulation) and
E13.5 (mid-gestation). Genotyping of these litters revealed that Ino80 KO embryos fail
to survive after implantation. Phenotype analysis of E5.5, E6.5 and E7.5 embryos
indicated that at E5.5 both WT and KO embryos had similar size and morphology,
however, once they implanted Ino80 KO embryos started to decrease in size and lose
their structural integrity by E7.5 (Figure 3.1 D, and data not shown). These observations
suggesting that Ino80 KO embryos fail to develop after implantation.
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Figure 3.1: Ino80 is Crucial for Mouse Embryonic Fibroblast Survival and Early Embryonic
Development.
A) Western blot analysis of Ino80 protein expression in wild type and Ino80 KO ESCs.
B) Growth rate of conditional Ino80 KO MEF induced by doxycycline treatment.
C) -galactosidase activity of Ino80 KO and WT MEFs at day 12 of culture,
Black arrows indicate -galactosidase positive cells.
D) Microscopic Comparison of E5.5-, E6.5-, and E7.5-day wild-type and homozygous Ino80 KO
embryo. For all experiments, N ≥3. * = t-test p-value ≤0.05.
This figure is done by Dr. Zhijun Qui.
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3.2 Ino80 KO Embryonic Stem Cells Are Viable and Pluripotent only in the
Presence of 2i
To characterize the effect of Ino80 KO on early embryo development further, we
isolated mESCs from pre-implanted blastocysts at E3.5 after heterozygous intercrossing. In order to maintain mESCs in culture, we have to use medium that maintains
ESC self-renewal and pluripotency. We cultured both WT and KO blastocysts on
gelatin-coated plates and culture media supplemented with LIF (Leukemia Inhibitory
Factor) and 2i. Both WT and KO blastocysts outgrew and we successfully isolated
mESCs from these outgrowths and maintained them at ground state pluripotency
(homogenous population of pluripotent mESCs) by addition of 2i to the media in the
presence of LIF (Figure 3.2 A). Under these conditions both WT and KO mESCs
proliferate at similar rates and stained equally for alkaline phosphatase, a marker of
pluripotency (Figure 3.2 B). However, upon 2i withdrawal from the media, Ino80 KO
mESCs started to scatter and differentiate suggesting that Ino80 is required to maintain
a metastable pluripotency state (Figure 3.2 C).
Moreover, the proliferation rate of Ino80 KO mESCs was lower than that of WT
cells even in the presence of 2i (Figure 3.2 D). Pluripotency and differentiation markers
of WT and Ino80 KO mESCs were quantified by qRT-PCR at different culture conditions
(Figure 2 E&F). qRT-PCR data analysis revealed that at ground state pluripotency.
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Ino80 KO ESCs express similar levels of pluripotency markers Nanog, Oct4, Klf4, Sox2,
and Essrb compared to WT cell Esrrb is a down-stream target in the GSK3/Tcf3
pathway and it is critical for modulating ESCs self-renewal (Martello et al., 2012). Both
C-myc and N-myc are required for pluripotency and self-renewal of ESCs(Varlakhanova
et al., 2010). Nanog, Oct4 and Sox2 are the core pluripotency markers, which are
interconnected by autoregulation loop (Boyer et al., 2005). In addition, the levels of
ectoderm, mesoderm, and endoderm markers were approximately equivalent in both
WT and Ino80 KO mESCs. In contrast, the levels of the respective pluripotency markers
are reduced in Ino80 KO mESCs under metastable pluripotency state (heterogeneous
population of pluripotent mESCs) (Figure 3.2 E). Based on the above results, Ino80 is
required for metastable state but not ground state pluripotency of mESCs.
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Figure 3.2: Ino80 KO ESC Are Viable and Pluripotent only in the Presence of 2i in the Culture
Medium.
A)Microscopic analysis of wild type and Ino80 KO pre-implantation E3.5 blastocysts.
B) The morphology of wild type and Ino80 KO ESCs grown in the presence of serum+2i+LIF or
serum+LIF.
C) Comparison of Alkaline phosphatase activity in wild-type and Ino80 KO ESCs after plating at in media
containing serum+2i+LIF or serum+LIF.
D) The growth rate of both WT and Ino80 KO cells.
E) Quantitative qRT-PCR analysis of gene expression in wild type and Ino80 KO ESCs maintained in
serum+2i+LIF.
F) q RT-PCR analysis of gene expression in wild type and Ino80 KO ESCs maintained in serum+LIF. For
all experiments N=3 biological replicates; * = t-test p-value ≤0.05).
A, B and C are done by Dr. Zhijun Qui. E and F are done by Veronica Peterkin.
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3.3. Ino80 KO ESCs Fail to Differentiate Using In Vitro Differentiation Models.
We utilized in vitro differentiation models to further characterize the role of Ino80
in mESCs differentiation. First, we created teratomas from both WT and KO mESCs
maintained in ground state pluripotency medium by inoculating these cells into the
opposing flanks of NOD/SCID mice. Once the control teratomas reached approximately
1cm in diameter we harvested tumors and conducted routine histological analysis on
tumor tissues. WT tumors differentiated into tissues from the three germ layers, which
include blood islands, keratin pearls, and neural rosettes from the ectoderm lineage,
both striated and smooth muscle from mesoderm and ciliated endoderm from the
endoderm lineage (Figure 3.3 A & B a’,b’,c’,d’,e’ and f’). However, Ino80 KO teratomas
displayed undifferentiated mesenchyme surrounded by a single layer of epithelial cells
(Figure 3.3 A & B g’, h’).
Secondly, we applied the embryoid bodies assay by suspension of WT and
Ino80 KO mESCs maintained in ground state pluripotency medium into medium
deprived of 2i and LIF. We harvested mESCs aggregates at three-day interval over nine
days and analyzed these tissues histologically. WT embryoid bodies formed an
organized mesenchyme filled with small cavities and surrounded by a defined layer of
endoderm, while KO embryoid bodies formed disorganized mesenchyme with
discontinuous endoderm (Coucouvanis et al.,1999) (Figure 3.3 C). We then quantified
the levels of pluripotency and differentiation markers in both WT and Ino80 KO
embryoid bodies. In contrast to pluripotency markers that exhibited approximately equal
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levels in both WT and Ino80 KO embryoid bodies, differentiation markers showed a
significant difference between WT and Ino80 KO embryoid bodies. The stem cell marker
Bmp4 was upregulated, and subsequently its downstream endoderm markers Gata6
and Gata4 (Cai et al., 2008 and Nemer et al., 2003). However, the levels of the
ectoderm marker Fgf5 (Herbet et al., 1990), the endoderm marker Hnf4a (Duncan et al.,
1994) and mesoderm markers Fgf8 (Crossley et al., 1995) and T (Wilkinson et al.,
1990) (Figure 3.3 D) were reduced suggesting that pluripotency genes are Ino80independent while differentiation markers are Ino80-dependent. To identify the
expression domain of Ino80, we used RNA in situ hybridization to determine where and
when Ino80 is expressed starting with E5.5 embryo to the E7.5 embryo relying on sense
and anti-sense probes. Results showed that Ino80 was widely expressed in E5.5 and
E6.5 embryos mostly in the EmE and ExE with less staining in the VE (Figure 3.4 A,B,
C).
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Figure 3.3: Ino80 is Essential for Embryonic Stem Cell Differentiation.
A) Low-magnification analysis of differentiation potential of teratoma derived from wild type and Ino80 KO
ESC (Scale bar = 500 µm).
B) High magnification analysis of teratomas derived from both wild type and Ino80 KO ESCs (Scale bar =
75 µm).
C) H&E analysis of 9-day embryoid bodies derived from of wild type and Ino80 KO 606 ESCs (Scale bar =
200 µm).
D) Gene expression analysis of differentiation markers in embryoid bodies derived from wild type or
Ino80 KO ESCs over 9 days. For all experiments, N=3 biological replicates; * = t-test p-value ≤0.05.
This figure is done by Dr. Zhijun Qui.
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3.4 Ino80 KO Embryos Fail to Gastrulate.
To further characterize Ino80 KO embryos, we applied the whole amount ISH to
determine the expression of known developmental markers at the pre-gastrulation and
gastrulation stages. We started with E6.5 embryos, the latest stage that failed develop,
yet retained structural integrity. E6.5 is the time of gastrulation where the formation of
the three germ layers (ectoderm, mesoderm and endoderm) occurs. Therefore, we
stained embryos with probes for the mesoderm marker Brachyury (T) that is first
detected in the pre-mesoderm cells and plays a role in the formation and organization of
mesoderm at the onset of gastrulation (Wilkinson et al., 1990). In contrast to WT
embryos, Ino80 KO embryos lack T expression, and presumably mesoderm
differentiation is defective (Figure 3.4 D). Prior to gastrulation a subset of VE cells at the
tip of the distal portion of the embryo migrate to the future anterior part to form the AVE
that is identified by Hex1, Lefty1 and Cer1 expression. Formation of the AVE is
essential for gastrulation. An analysis of these markers demonstrated that Ino80 KO
embryos did not express the AVE markers Cer1, or Hex1, suggesting a failure to form
the AVE. The ExE marker, Bmp4 is a member of the TGFβ family members and it is
known to inhibit the formation of AVE (Winnier et al., 1995). Ino80 KO embryos
exhibited very low expression of Bmp4 in the ExE (Figure 3.4 D). Collectively, these

50

results support the hypothesis that Ino80 KO embryos fail to gastrulate, do not specify
the AVE and have abnormal Bmp4 expression in the ExE.
Initiation of the P-D axis occurs at E5.5 when a subset of PrE cells differentiate at
the distal part of the embryo to form the DVE. These cells are the precusors to the
AVE. Because INO80 KO embryos lacked the AVE, we hypothesized that the DVE
could be defective. Therefore, we measured the levels of Cer1, Hex1 and Bmp4 at E5.5
embryos using whole mount ISH. Results revealed that the DVE markers, Cer1 and
Hex1, were completely absent and the Bmp4 expression domain is mislocalized to the
EmE. To further verify the localization of Bmp4 expression we performed a double
staining of Bmp4 and Otx2. Otx2 is a known EmE marker at E5.5 embryos (Daisuke et
al., 2004). As expected, we found an overlap between the two markers in the EmE
(Figure 3.4 E) suggesting that Bmp4 expression is lower in the EmE in Ino80 KO
embryos. Because, Bmp4 is a known regulator of the DVE these results suggest that
In80 KO embryos fail to develop because of aberrant Bmp4 expression, a known
negative regulator of the DVE. However, the defects in DVE specification could also
result due to a general defect in VE. To test this possibility, we measured the levels of
Hnf4a. Hnf4a belongs to the steroid hormone receptor family and it is expressed in VE
endoderm at E5.5 and in the proximal VE at E6.5-E7.5 (Duncan et al., 1994). We
observed reduced levels of Hnf4a in Ino80 KO embryos suggesting that Ino80 KO
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embryos fail to specify the DVE due to mis-regulation of the inhibitory molecule Bmp4
and possibly a defective VE (Figure 3.4 D).
PrE is the origin of several extra-embryonic tissues including that VE, EmVE,
ExE and DVE (Stephenson et al., 2012). At E4.5, a subset of PrE cells differentiates into
DVE cells that are retained at the distal part of the embryo. Consequently, the defects in
DVE formation could be due to defect in PrE differentiation. To test this hypothesis, we
stained E4.5 embryos with DVE markers Lefty1 and Hex1 and observed similar levels of
these markers in both WT and Ino80 KO embryos suggesting normal differentiation of
PrE cells. Also, the levels of the EPI specification marker Nanog in both WT and Ino80
KO embryos was normal suggesting that its development in not INO80 dependent
(Figure 3.4 D). The decreased embryo size at E6.5 is not likely due to cell death because
TUNEL staining at this stage did not observe a significant difference between WT and
Ino80 KO embryos (Figure 4 F). Based on the above results, Ino80 KO embryos fail to
establish the P-D axis since they lack the ability to specify the DVE at E5.5. This could
be due to abnormal expression of Bmp4 in the EmE, a known negative regulator of DVE
differentiation or defects in VE differentiation.
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Figure 3.4: Ino80 is Widely Expressed in Embryonic Tissues and is Essential for Establishing the
Proximal-Distal Axis of the Post-Implantation Embryo.
A) Whole mount RNA in situ hybridization using either sense or antisense Ino80 riboprobes in embryos at
E5.5, E6.5 and E7.5 embryos.
B) High magnification of Ino80 ISH exhibits reduced antisense Ino80 riboprobe staining in the visceral
endoderm (VE) in E6.0-day embryos.
C)Frozen sections of sagittal and cross-sections through the ExE and EPI stained with antisense Ino80
riboprobe.
D) Whole mount RNA in situ hybridization of E6.5, E5.5, and E4.5 embryos were performed with
antisense riboprobes for markers of tissue differentiation. All ISH are done by Dr. Zhijun Qui except
Hnf4a ISH.
E) Whole mount ISH of E5.5 embryos were performed with antisense probes to the ExE marker Bmp4
(purple color) and the EmE marker Otx2 (magenta color).
F&G) Whole mount analysis and quantification of TUNEL positive cells in wild type and Ino80 KO E6.5
embryos. N=3 biological replicates.
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3.5. Ino80 Regulates Bmp4 Expression During Embryonic Stem Cell
Differentiation In Vitro.
Results from (Figure 3.3 D) showed upregulation of Bmp4 in Ino80 KO embryoid
bodies. In addition, ISH experiments showed undetectable expression of Bmp4 in the
EXE, and its upregulation in the EmE, suggesting a possible direct role of Ino80 in the
regulation of Bmp4 expression. To identify how INO80 regulates Bmp4 expression, first
we induced mESCs differentiation in vitro by LIF and 2i withdrawal from the media. LIF
withdrawal from media is known to promote cell differentiation into mesoderm and
endoderm lineages (Sharova et al., 2007 and Ying et al., 2003). We collected cells at
three-day time interval over nine days. Then we quantified the RNA levels of Bmp4 and
other differentiation markers. Results from monolayer differentiated cells were
consistent with embryoid bodies experiments where Ino80 KO mESCs exhibited
increased levels of Bmp4 expression, reduced levels of DVE markers Cer1, Hex1 and
Lefty1 and approximately equal levels of the endoderm markers Gata4 and Gata6
(Figure 3.5 A). In mESCs an upstream enhancer mediates transcription of Bmp4
through interaction with Med23 and ETS1 (Wanqu et al., 2015).
We applied ChIP analysis using monolayer differentiated mESCs cells to identify
which Bmp4 regulatory element is occupied by INO80. As shown in Figure 3.5 B&C,
Ino80 is preferentially localized to the promoter region of Bmp4. Next, we used FAIRE
to detect the chromatin status at Bmp4 promoter under the same condition. Results
showed an open chromatin structure at ~ 1.5 Kb upstream of Bmp4 promoter (Figure
3.6 A, B). SP1 is a transcription factor that is known to activate Bmp4 expression (Ebara
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et al., 1997), so we applied ChIP experiment to monitor its localization at the Bmp4
promoter, and we observed that SP1 occupies the promoter region of Bmp4 with
enrichment of the active histone marker H3K4me3 (Figure 3.6 C, D). Based on the
above data, we provide a model where the chromatin remodeling factor INO80 is
required for DVE specification in pre-gastrula mouse embryo by negative regulation of
Bmp4 in the EmE and by positive regulation of Bmp4 in the ExE (Figure 3.7) and also
by its effect on VE differentiation through Hnf4a down-regulation.

55

Figure 3.5: Ino80 Regulates Bmp4 Expression by Occupying its Promoter.
A) qRT-PCR quantification of Bmp4, Hex, Lefty1, Cer1, Gata6, and Gata4 during ESC differentiation in
the absence of 2i+LIF in monolayer.
B) Cartoon showing the cis-regulatory elements of Bmp4 gene, location of upstream enhancers, and
downstream gene Gm15217 to illustrate position of PCR amplicons used in ChIP experiments. Amplicons
are shown as black bars labeled 1-6ChIP of both wild type and Ino80 KO ESC after differentiation as a
monolayer for 6 days in serum containing media in the absence of 2i+LIF.
For all of the above experiments N=3 biological replicates; * = t-test, p-value ≤0.05.
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Figure 3.6: The Bmp4 Promoter is More Accessible to Positive Regulatory Factors upon Ino80
Deletion.
A) Cartoon showing ~ 1.5Kb of the Bmp4 promoter and the location of PCR amplicons used in FAIRE
experiments.
B) FAIRE was performed with wild type and Ino80 KO ESC after differentiations for 6 days in culture
media containing serum and lack both 2i+LIF.
C) Increased occupancy of active chromatin mark H3K4me3 at Bmp4 promoter in Ino80 KO ESC as
compared to WT. ChIP was performed using wild-type and Ino80 KO ESC after differentiation as a
monolayer for 6 days in serum containing media lacking 2i+LIF.
D) Increased occupancy of the positive transcription factor SP1 at Bmp4 promoter in Ino80 KO ESC as
compared to WT ESCs. ChIP was performed with wild type and Ino80 KO ESC after differentiation in
serum containing media lacking 2i+LIF as a monolayer for 6 days.
For all of the above experiments N=3 biological replicates; * = t-test, p-value ≤0.05.
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A Proposed Model INO80 Role in DVE Formation during Early Mouse Development.

Figure 3.7: Model of Ino80 KO Effect on Bmp4 Gene Expression and its Consequences on the
Establishment of the Proximal-Distal Axis in Early Mouse Embryo.
We propose a model where Ino80 KO embryos upregulate Bmp4 expression in the EmE, which in turn
repress the expression of the DVE markers Cer1, Hex, and Lefty1. Consequently, Ino80 KO embryos lack
the DVE in part due to mis-localized Bmp4 expression and fail to gastrulate.
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CHAPTER FOUR
Discussion and Future Directions

4.1 Discussion
4.1.1 Early Embryonic Lethality Due to Disruption of the ATP-Dependent
Chromatin Remodeler INO80
Mammalian development is a complex process in which one cell zygote give rise
to an organism. An organism is composed of multiple cell types that develop into
specific tissues and organs. Although all these cells share the same genetic DNA
sequence, the chromatin state (DNA packaging) is distinguished in each cell type to
establish and maintain different cell identities. The chromatin state is modified by many
mechanisms including histone post-translation modifications (for example, histone
acetylation, and methylation), histone variants, and DNA modifications like cytosine
methylation and/or ATP-dependent chromatin remodeling complexes (Ho et al., 2010
and Chen et al., 2014).
Genetic studies utilizing mouse models showed essential roles of chromatin
remodelers in development. Chromatin remodelers are important for both pre- and postimplantation phenotypes suggesting that they regulate specific developmental
pathways. NURD is required for maintaining the balance between self-renewal and
differentiation. Pre-implantation lethality occurs upon deletion of the methyl CpG-binding
domain protein 3 gene (MBD3) that encodes the core component of NURD (Kaji et al.,
2007). MOF/TiP60 null embryos fail to implant and survived blastocysts are defective in
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morphology and growth suggesting an essential role for the complex in cell survival,
pluripotency and self-renewal (Thomas et al., 2008). Mouse embryos null for the
SWI/SNF ATPase subunit Brg1 die before implantation suggesting a potential role of
Brg1 in self-renewal and pluripotency in mESCs (Bultman et al., 2006). Other chromatin
remodeling factors such as NURF and CHD7 exhibit post-implantation lethality upon
deletion. NURF (BPTF) KO embryos are defective in gastrulation and differentiation of
mesoderm and endoderm (Landry et al., 2008). CHD7 null embryos showed multiple
defective tissues and perinatal lethality (Hurd et al., 2007). In the present study, we
show that Ino80 KO embryos fail to gastrulate and exhibit post-implantation lethality.
4.1.2 The Differential Effect of Ino80 KO in MEFs and mESCs
DNA replication is an essential component of cell proliferation. Chromatin
remodeling at replication origins is an essential step in DNA replication especially at
stalled forks. Ino80 is required for DNA replication where it disrupts nucleosomes in
front of replication fork to facilitate polymerase movement and DNA unwinding at
replication origin (Karina et al., 2012). It is also required to re-assemble disrupted
nucleosomes behind the fork. Lee et al. showed that Ino80 is stabilized by BAP1
through de-ubiquitination and BAP1 recruits Ino80 to replication fork by its interaction
with ubiquitinated H2A. These functions might explain in part the early embryonic
lethality in Ino80 KO mice, non-viable Ino80 KO MEFs, and slow growth rate of Ino80
KO ESCs (Min et al., 2013 and Lee et al., 2014).
Our results showed that Ino80 KO MEFs have significantly higher beta-
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galactosidase than WT MEFs. This is consistent with a recent study, which showed that
Ino80 is required for MEF proliferation, and its deletion delayed S-phase progression
and decreased BrdU (bromodeoxyuridine) incorporation (Hur et al., 2010, Min et al.,
2013 and Lee et al., 2014). Although the same study reported that Ino80 KO ESCs were
not viable. In our hands, Ino80 KO ESCs were viable when cultured in medium supplied
with 2i plus LIF to maintain ground state pluripotency. ESCs that grow in 2i medium
exhibit global hypomethylation of DNA that is similar to hypomethylated ICM at E3.5
(Leitch et al., 2013). DNA hypomethylation alters chromatin structure to promote gene
activation (Feinberg et al., 1983). INO80 is involved in regulation of gene expression
(Ebbert et al., 1999), occupies the promoters of pluripotency genes in ESCs, and
regulates their expression (Li et al., 2014). In addition, INO80 replaces the histone
variant H2A.Z with H2A. H2A.Z occupies promoters of poorly transcribed genes (Zhang
et al., 2005), possibly to facilitate their expression (Manolis et al., 2011). It is plausible,
and I hypothesize that DNA hypomethylation of ESCs in ground state activates gene
expression, compensating for INO80 functions in maintaining gene expression. These
same compensatory effects would not be relevant in MEFs, which have
hypermethylated promoters, and require INO80 to maintain gene expression.
In contrast to MEFs, mESCs exhibit unique characteristics to stay pluripotent.
mESCs are characterized by the ability to self-renew in vitro while maintaining
pluripotency, i. e. the capacity to differentiate into a broad number of cell types that
originate from the three primary germ layers endoderm, mesoderm and ectoderm
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(Evans and Kaufman, 1981; Martin, 1981). The potential to self-renew is marked by two
main characteristics: highly rapid proliferation and high telomerase activity. The high
proliferation rate of mESCs necessitate unique cell cycle, which have extremely short
G1 phase that is devoid of regulation at the G1–S transition due to the absence of cyclin
D and the presence of hyperphosphorylated retinoblastoma (RB1) protein (Savatier et
al., 1996; Burdon et al., 2002). Both c-Myc and Klf4 are essential factors for mESCs
pluripotency (Kazutoshi et al., 2006). Klf4, which is known to repress p53 directly
(Rowland et al., 2005), while c-Myc, suppresses the expression of p21CIP1 (Seoane et
al., 2002). Both p53 and p21CIP1 are involved in cell cycle regulation and their
repression facilitate cell cycle progression in mESCs. mESCs express high levels of
TERT and exhibit high telomerase activity. TERT is a ribonucleoprotein enzyme, which
synthesis telomeres to maintain telomere homeostasis in mESCs and prevents
telomeres fusion to keep cells genetically stable (Wong et al., 2010). This difference in
cell cycle regulation and proliferation suggest that mESCs could compensate for Ino80
KO while MEFs could not.
4.1.3 Ino80 KO Effect on the Pluripotency of mESCs.
In our model, Ino80 is required for metastable but not ground state pluripotency
in Ino80 KO mESCs as similarly observed for Mbd3 KO mESCs (Kaji et al., 2007).
Ino80 KO mESCs exhibited WT pluripotent phenotype when those cells are maintained
in medium that promote ground state pluripotency (2i+LIF). However, when those cells
maintained in medium that induce metastable pluripotency (LIF only) they differentiate
and lose their pluripotent phenotype. 2i can closely mimic the in vivo environment for
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ICM pluripotency (Marks et al. 2012) and mask defective pluripotency due to Ino80 KO.
Our results contradict the finding that Ino80 is required for mESCs pluripotency and preimplantation (Wang et al., 2014). This could be due to difference in Ino80 KO methods,
since referenced study used siRNA to KD Ino80, which could affect both maternal and
embryonic tissues (Li et al., 2014). In addition, the referenced study maintained the cells
in culture medium that promotes metastable pluripotency, culture conditions that we
have shown requires INO80. Another possibility, at the metastable pluripotency state,
nucleosomes are highly modified by the activation marker H3K4me3 (Marks et al.,
2012), which could recruit activating histone readers to promote gene expression and
compensate for the loss of INO80. Under these conditions factors like Sox2, Nanog,
Oct4, which require INO80 in the metastable state, would sufficiently transcribed
maintaining pluripotency.
4.1.4 The Reduced Size of Epiblast in Ino80 KO Embryos
The Ino80 KO embryos have reduced size at E6.5, which could be due to
reduced proliferation or increased apoptosis rates. Ino80 KO did not affect the levels of
apoptosis, as the rates of cell death were essentially similar in both WT and Ino80 KO
embryos. It has been shown that E5.5 embryo undergo dramatic increase in
proliferation to attain a certain number of cells to start the gastrulation at E6.5 (Snow et
al., 1977). Consequently, the reduced embryo size could be due to the reduced
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proliferation rate of Ino80 KO mESCs. This possibility could be further investigated by
the determination of the epiblast proliferation rate at E6.5 through BrdU labeling of
embryos and/or the measure of cell proliferation using immuno-histochemistry of
phosphorylated histone H3 levels in the conceptus by at E6.5 and E7.5 (Landry et al.,
2008).
4.1.5. Ino80 KO Effect on the Proximal-Distal Axis Establishment
The A-P axis establishment is induced by AVE formation at the anterior part of
pre-gastrula embryo, which in turn promotes gastrulation (Beddington and Robertson,
1999). Both TGF-β signaling molecules, Nodal and Bmps, are involved in the regulation
of DVE formation at E5.5 (Brennan et al., 2001 and Soares et al., 2005). The
antagonism between these two molecules at the distal part of the embryo is the
molecular basis of DVE formation. Nodal -/- embryos fail to specify embryonic VE which
is required to develop the DVE (Mesnard et al., 2006). Furthermore, inhibition of Nodal
signaling abolished DVE formation, and promoted aberrant Bmp4 expression at the
DVE (Yamamoto et al., 2009). Although the levels of Nodal transcripts were similar in
both WT and Ino80 KO embryos, Nodal could be unprocessed, and therefore not
functional in Ino80 KO embryos, resulting in defective DVE formation for reasons
discussed above (Mesnard et al., 2006).
In WT embryos, Bmp4 is expressed in the EXE at the pre-gastrula and gastrula
stages. Limited expression of Bmp4 in the ExE is required for DVE establishment,
because it is a negative regulator of the DVE (Rodriguez et al., 2005; Mesnard et al.,
2006)(Yamammoto et al., 2009). In addition, Bmp signaling is required for VE
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differentiation at E5.5, and it cooperates with Nodal signaling to promote epiblast
proliferation. In our model, Bmp4 expression is up regulated in the EmE thereby
emitting an inhibitory signal for DVE formation. Defective DVE formation could be also
result from impaired VE as suggested by the down-regulation Hnf4a, possibly also a
result from aberrant Bmp4 expression (Figure 4 D).
VE is the main expression domain of Hnf4 during gastrulation and its disruption
results in defective gastrulation (William et al., 1994). VE is an outer layer of epithelial
cells around the embryo. The tight junctions between these epithelial cells are essential
for nutrition and small molecule delivery to the embryo. It is also the main site for
production of survival signals (Jollie et al., 1990). It would be interesting to examine the
endocytic activity of VE in Ino80 KO embryos, which could contribute to the lethality
phenotype. Signals from ExE are required for VE patterning and DVE formation
(Richardson et al., 2006). To determine if VE defects in Ino80 KO embryos are the
result of an overall defective ExE, we can monitor the expression pattern of additional
ExE markers including, Fgfr2, Plet1 and Talia using in situ hybridization (Stephen et al.,
2007). FGF signaling is involved in the development of extraembryonic tissues and
FGFR2 is required for ICM differentiation and specific functions of the trophectoderm
(Arman et al., 1998). The initial establishment of the cardiovascular network occur
during gastrulation at E6.5 (Nowotschin et al., 2010). This process is largely dependent
on activation of the vascular endothelial growth factor (VEGF) signaling pathway. The
vascular endothelial growth factor receptor 2 (VEGFR2/Flk1) is critical for the
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development of the primitive capillary plexus during embryogenesis (Klagsbrun and
Soker, 1993). Flk1 is a receptor tyrosine kinase that is expressed in the extra-embryonic
ectoderm. Flk-1 KO embryos die at E8.5-E9.5 due to defect in the development of
hematopoietic and endothelial cells (Shalaby et al., 1995). We can also quantify the
expression of these angiogenic markers VEGFR2 and Flk1 at E6.5 to detect any
defective angiogenesis phenotypes associated with Ino80 KO. While defects in
angiogenesis are unlikely to contribute the lethality of Ino80 KO early embryos, it could
reveal important functions for INO80 in these processes, which would have relevance to
our understanding of INO80 in the adult.
4.1.6. INO80 Regulation of the Bmp4 Promoter
The roles for INO80 as a chromatin-remodeling factor that regulates gene
expression is well established. Towards this end, transcription factors can recruit INO80
to target genes where it can modulate chromatin and activate or repress expression.
Our results demonstrated a differential regulation of Bmp4 by INO80 at the
transcriptional level in the ExE and EmE where Bmp4 expression is inhibited in ExE and
upregulated in EmE. More specifically in the EmE we predict that INO80 is modulating
the chromatin structure at Bmp4 to prevent access of regulatory factors such as SP1.
How INO80 is recruited to the Bmp4 promoter is unknown, but could be through
interactions with unknown transcription factors. Also, enhanced H3K4me3 at the Bmp4
promoter in Ino80 KO ESCs could recruit other unknown regulatory factors that promote
Bmp4 expression beside SP1. For example, the mediator complex is a multi-protein
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complex that mediates a connection between transcription factors and the mRNA
polymerase II apparatus to regulate gene activity (Kagey et al., 2010). In ESCs, the
mediator subunit med23 recruit ETS1 (member of the ETS family transcription factors)
to the Bmp4 promoter and enhancer to facilitate their communication and enhance
Bmp4 expression (Wanqu et al., 2015). In addition, USF (upstream stimulatory factor)
binds the Bmp4 promoter and activate its expression (Ebara et al., 1997). The
recruitment of either of these factors could be repressed by INO80 in the EmE. To test
these hypotheses ChIP analysis of these factors at the Bmp4 promoter in Ino80 KO
ESC would be performed which could reveal additional regulatory factors of Bmp4.
4.2 Future Directions
The role of mouse INO80 in DNA repair, DNA replication, the cell cycle regulation
and telomere replication demonstrates it’s requirement for the maintenance of genomic
stability (Wu et al., 2007 and Hur et al., 2010). Mouse Ino80 deletion reduced the
tumorigenic potential of oncogenic transformed cells by reduction in cell proliferation
and impairment of their ability to form soft agar colonies (Min et al., 2013). In addition,
mouse Ino80 haploinsufficiency in a p53 KO background induced a shifted in the tumor
spectrum form lymphoma to sarcoma suggesting a role for Ino80 in tumor suppression
and determination of the cells fate that will initiate cancer (Min et al., 2013). A recent
study showed that INO80 promotes cervical cancer proliferation through activation of
Nanog, expression and its inhibition reduced cell proliferation in vitro and in vivo (Hu et
al., 2016). The INO80 complex is an enzyme with multiple binding sites for its
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substrates that could be targeted by small molecules to inhibit its activity. It has been
shown that HSA/PTH and Snf2 ATPase domains of human Ino80 are essential for its
remodeling activity (Lu et al., 2011). Targeting these subunits will inhibit the complex
remodeling and enzynmatic acitivities. However, the consequences for INO80 depletion
could be very detrimental to normal cells. The INO80 complex is crucial for essential cell
processes such as DNA replication, cell cycle regulation, chromosomes segregation
and telomere maintenance (Ashby et al., 2009).
Beyond cancer, the defective differentiation of Ino80 KO ESCs suggests a
possible role of Ino80 in tissue regeneration. This could be tested by tissue specific KO
of Ino80 in the liver for example and chemical induction of liver injury followed by
assessment of the recovery rate in both WT and KO mice (Dimitrios et al., 2013).
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PART II.

Role of the Nucleosome Remodeling Complex NURF in AntiTumor Immunity
Chapter 5. Background and Literature Review

5.1 The Immune System
The immune system is classically divided into innate and adaptive immune
systems. The innate response is fast and it includes a broadly distributed variety of
myeloid and lymphoid cells (e.g. monocytes, neutrophils, macrophages, dendritic cells
and natural killer (NK) cells). However, the adaptive immune response is slow since it
requires proliferation and differentiation of effector cells, which include T and B cells. T
and B cells express an unlimited repertoire of antigen receptors that are produced by
gene rearrangement (Vivier et al., 2011). NK cells are a type of lymphocytes that plays
an important role in innate immune processes, including early defense against different
pathogens and tumor transformation through a limited repertoire of germline-encoded
receptors. They comprise up to 15% of peripheral blood lymphocytes and are found in
peripheral tissues such as liver, spleen, peritoneal cavity and placenta (Trinchieri et al.,
1989).
5.2 NK Cell Development
NK cells was first discovered by Rolf Kiessling, 40 years ago, when he
characterized a subset of large granular lymphoid cells that directly lyse tumor cells in
vitro without prior sensitization a phenomenon known as ‘natural cytotoxicity (Kiessling
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et al., 1975). The evolutionary origin of NK cells is not completely understood. NK cells
complete functional and phenotypic maturation in the bone marrow (BM) and their
functional differentiation requires their direct interaction with BM stromal cells in vitro
and in vivo (Caraux et al., 2006). The development of NK cells can be divided into
several stages (Figure 5.1). The earliest stages involve the commitment of
hematopoietic stem cell (HSC) in BM into a common lymphoid progenitor (CLP) that can
give rise to NK, T and B cells. The CLP is characterized by expression of IL-7R
(CD127), c-kit (CD117), Sca-1, and Flt-3 (CD135) (Kondo et al., 1997). The CLP
differentiates into bi-potential T/NK progenitor cell reflecting the resemblance between
NK and T cells (Rodewald et al., 1992 and Schmitt et al., 2006). In order for the T/NK
cell progenitor to commit to NK progenitor, they acquire the IL-2/15Rα subunit (CD122).
Accordingly, mice deficient in IL-15 receptor or its signaling components is defective in
NK cell development (Suzuki et al., 1997, Ogasawara et al., 1998, and Kennedy et al.,
2000). NK progenitors develop into immature NK (iNK) cells that lose IL-7R expression
and acquire expression of NK1.1 (Rosmaraki et al., 2001). Immature NK cells develop
into functionally mature NK cells by expression of CD11b, CD43, Ly49 receptors, and
CD49b (DX5). Once mature these NK cells have the ability to lyse target cells and
produce IFN-γ (Kim et al., 2002).
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Figure 5.1: Cartoon Illustrating the Stages of NK Cell Development.
NK cells are derived from the CLP, which differentiates into NKP/ILCP population distinguished from the
NKP by lack of CD122 expression. The NKP, begin to express NK cell markers NK1.1 and NKp46, and
as they further mature they acquire expression of DX5 (CD49b) and CD11b while losing expression of
CD27. As NK cells mature they also gain functional competence, expressing lytic molecules and
cytokines such as IFNγ. Color-coded cell surface proteins indicate the stage where proteins are first
expressed. Loss of a specific cell surface marker is indicated by parentheses (Geiger et al., 2016).
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5.3 Regulation of NK Cytotoxicity
NK cell education/licensing is the process by which they become functionally
competent (Fernandez et al., 2005). There are many models for NK cells’ education:
(1). The arming hypothesis proposes that the self-MHC class I specific receptors
generate the signals necessary to confer the licensed phenotype, whereas signaling
from inhibitory receptors mediates functional maturation in an active way. (2) The
disarming hypothesis suggests the presence of a self-specific activation receptor. If
unperturbed, the activation of this receptor results in chronic stimulation and an anergiclike, hypo-functional state. The self-MHC-I specific receptor then modulates the action
of the activation receptor and leads to a licensed NK cell (Elliot et al., 2011). (3) The
rheostat model suggests that NK cells’ education depend on the strength of the
inhibitory signal that is received which can be tuned up or down in a quantitative manner
(Petter et al., 2010).
Once “educated”, NK cells are able to kill pathogen infected or transformed cells
without prior sensitization. NK killing occurs though a variety of mechanisms, including
perforin/granzyme granule-mediated exocytosis, and/or signaling through the TNF
death receptor family members (Smyth et al., 2005). The granule exocytosis pathway
depends on NK cytotoxic and cytoplasmic granules, which resemble the secretory
lysosomes. These granules contain the mediators of a diverse range of cell-death
pathways that have evolved to rapidly kill target cells. The major components of these
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granules are perforin, a membrane-disrupting protein, and granzymes. Both are related
to a family of serine proteases with various substrate specificities. Perforin gene
disruption in mice indicated that perforin is essential for NK cell cytotoxicity and it has an
indispensable role in granzyme-mediated apoptosis (Kagi et al., 1994). Granzymes are
highly redundant, there are eleven granzymes, ten of these (granzymes A–K, M and N)
are expressed in mice, and five in humans (granzymes A, B, H, K and M) (Smyth and
Trapani, 1995 and Trapani et al., 2000). Granzymes trigger cell apoptosis either directly
or via activation of caspases (Heusel et al., 1994).
The death receptor pathways involve the interaction between a death receptor on
target cells and their cognate ligands on NK cells, which results in caspase-dependent
apoptosis. The death TNF (Tumor necrosis factor) ligands on NK cells includes TRAIL,
FasL and other mediators. TRAIL (TNF-related apoptosis-inducing ligand), is a type II
transmembrane protein that belong to the TNF superfamily. Both mouse and human NK
cells express high levels of TRAIL in response to IL-2, IL-15 and IFN treatment
indicating a broad role of TRAIL in innate immune response. The cytotoxic and antimetastatic activity of NK cells toward TRAIL sensitive tumor cells is in part dependent
on TRAIL (Takeda et al., 2001a) interaction with TRAIL-R1 (DR4) and TRAIL-R2 (DR5)
resulting in an apoptotic signal (Degli-Esposti, 1999). In addition, FasL expression by
NK cells suppress tumor growth in vivo (Bradley et al., 1998). In response to IFNγ
secretion, NK cells directly induce Fas expression on tumor cells to kill them in a Fasdependent manner (Screpanti et al., 2001). In addition, TNF deficient mice were
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defective in rejection of NK sensitive tumor cells indicating that the death receptor
pathway is an important mechanism for NK cells clearance of tumor (Smyth et al.,
1998).
5.4 Regulation of NK Cells Activity
The regulation of NK cells is not dictated by one dominant receptor with high and
specific affinity towards one particular antigen. Instead, each NK cell has broad
specificity, which is mediated by the expression of multiple activating and inhibitory
receptors. For many years, NK cells were considered as non-specific effectors until
Klas-Karre first postulated his ‘missing self’ hypothesis in 1986 (Karre et al., 1986).
According to this theory, NK cells can recognize and spare cells that express selfmarkers the MHC class I molecules. Based on this hypothesis, the activity of NK cells is
based on their ability to sense what is missing on a target, but present in a healthy cell.
The ‘missing self-hypothesis’ predicted that NK cells must express inhibitory receptors
that interact with the self MHC class I molecules and deliver an inhibitory signal upon
interaction. However, NK-mediated killing is regulated by other non-MHC ligands.
Indeed, certain MHC class I negative molecules are resistant to NK killing and others
with MHC class I molecules are NK susceptible targets. Thus, NK cell activity is not only
dependent on the absence of the inhibitory signal but also require the engagement of
their activating receptors (Moretta et al., 1995, Markel et al., 2002). The following
sections will describe the central components that participate in the delivery of both
inhibitory and activating signals and determine the overall regulation of NK activity, as
known today.
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5.4.1 Inhibitory Receptors
All of the well-defined NK inhibitory receptors contain one or more copies of the
immune receptor tyrosine-based inhibitory motif (ITIM) in their cytoplasmic tail. Upon
ligation of the receptor, the Tyr residues in the ITIM are phosphorylated (probably by
Src family kinase) and recruit phosphatases via their SH2-domains. The recruitment of
the phosphatases to a membrane proximal location dampen or prevents activating
signals. Under normal circumstances, these inhibitory signals predominant those
delivered by activating receptors (Lanier et al., 2005). However, experimental evidence
shows that the degree of inhibition is proportional to the level of inhibitory ligands
expressed on the target cells. In addition, when multiple costimulatory receptors are
spontaneously engaged, or when a sufficient activating signal is delivered (by the
ligation of a potent lysis receptor), NK cells are capable of overcoming the inhibition and
destroy the target in spite of the existence of high levels of inhibitory ligands (Moretta et
al., 2002).
NK inhibitory receptors can recognize ‘classical’ and ‘non-classical’ MHC class I
ligands. The two major families of MHC-specific inhibitory receptors identified in humans
include; The Ig superfamily, which includes the killer and leukocyte immunoglobulin-like
receptors, designated as KIR and LIR, respectively and the C-type lectin receptor
superfamily in both human and mice (Raulet et al., 2001). The KIR proteins belong to
the Ig-superfamily of proteins have 2 or 3 immunoglobulin (Ig)-like domains and either a
short or a long cytoplasmic tail. The KIR molecules with a long cytoplasmic tail signal
via ITIMs to transduce a negative signal, whereas the KIRs with a short cytoplasmic tail
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signal via ITAM mediated recruitment of DAP12 and thus inhibit the NK cell’s activity
(Raulet et al., 2001).
The KIR family in humans, the lectin-like Ly49 molecules in mice and
CD94/NKG2A heterodimers in both species are the most relevant and best-studied
inhibitory receptors. The KIR loci in human and the Ly49 loci in mice are highly
polymorphic both in terms of gene numbers (14 genes and 2 pseudogenes) and alleles
present. Other inhibitory molecules include KLRG1 (Killer Cell Lectin-Like Receptor
Subfamily G member 1), TIGIT (T cell immunoreceptor with Ig and ITIM domains), NKRP1A or LILRB2 (Leukocyte immunoglobulin-like receptor subfamily B member 2) (Aron
et al., 2006). These molecules detect cadherin, CD155 and CD112 and/or a broad array
of HLA-A, -B, -C and -G alleles and thus complement the capability to distinguish “self”
from “altered self” or “missing self”. All mentioned receptors signal via ITIMs that
subsequently recruit and activate the phosphatases SHP1 and SHP2, thus decreasing
the absolute signal strength.
Importantly, NK cells in one given individual can vary in terms of which KIR
alleles are expressed and the level of expression creating different populations of KIR
positive NK cells. The fact that KIR alleles are expressed in a largely random manner,
unlinked from the host’s HLA haplotypes, is troublesome as this potentially could cause
NK cell mediated autoimmunity. Therefore, an education system exists in which
developing NK cells acquire self-tolerance if they fail to bind to self-HLA. This state of
hypo-responsiveness not only affects reactivity to self but also affects stimulation with
MHC class I negative tumor cells, or plate-bound antibodies against various stimulatory
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receptors. The same phenomena can be observed when mice or human individuals lack
HLA class I molecules (Natalia et al., 2014).
5.4.2 Co-stimulatory NK receptors
Surprisingly, most the MHC class I-dependent inhibitory receptors have a
stimulatory homolog counterpart. Under normal conditions, the affinity of stimulatory
receptors to their MHC class I ligands is lower than their inhibitory counterparts are so,
the inhibitory signal dominate the stimulating ones (Vales-Gomeset al., 1999). A
possible explanation is that these receptors may be involved in a different context and
recognize additional ligands. For example, both the CD94/NKG2C stimulatory and its
inhibitory counterpart the CD94/NKG2A, recognizes HLA-E. However, NKG2C is
activated by peptides derived from the heat shock protein Hsp60 bound to the HLA-E
molecules under stress conditions (Michaelsson et al., 2002).
5.4.3 NK Activating Receptors
The difference between NK co-stimulatory and activating receptors is their ligand
specificity. While the stimulatory receptors recognize MHC class I ligands, the triggering
receptors recognize non-MHC ligands. Moreover, the activating receptors are able to
mediate direct killing of targets and therefore considered as lysis receptors. In resting
NK cells, the cytolysis activity requires synergistic stimulation of more than one receptor
(Bryceson et al., 2005). Progress in the understanding of NK cell biology revealed that
NK cell activation is not only dependent on the absence of the inhibitory signal; it also
requires efficient activating signals. This theory is based on the discovery of a set of NK
activating receptors that are able to directly induce cytotoxicity and cytokine production
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upon engagement. The major NK activating receptors include the NKG2D, CD16 and
the NCRs (natural cytotoxic receptors), which include NKp46, NKp44 and NKp30
(Moretta et al., 2002). In addition, some NK receptors are thought to serve as
‘costimulatory’ receptors that enhance signaling of active receptors but cannot mediate
cytotoxicity on their own. The following sections will discuss the major NK triggering
receptors and their ligands.
NKG2D is a type II transmembrane glycoprotein that is expressed on the surface
of all human and mouse NK and a subset of T cells (Bauer et al., 1999 and Jamieson et
al., 2002). The identified ligands for NKG2D include MICA, MICB and ULBP1-4 in
human and H60, Rae1 in mice (Bauer et al., 1999, Castriconi et al., 2003 and
Sutherland et al., 2002). These proteins are stress inducible cellular ligands that are
structurally homologous to MHC class I proteins (Li et al., 2001). NKG2D is involved in
anti-viral defense mechanisms. For example, CMV infection leads to upregulation of
NKG2D ligands (Groch et al., 2001). In response to this challenge, CMV developed
evasion mechanisms, which include the expression of UL16 protein (Cosman et al.,
2001). UL16 binds NKG2D ligands and prevents their transport to the surface of
infected cell to reduce NK cytolysis activity (Wu et al., 2003 and Dunn et al., 2003).
In tumors, NKG2D ligands are upregulated due to genotoxic stress and stalled
DNA replication and in vivo, expression of NKG2D ligands induce NK-mediated
elimination of NK-resistant tumor cell lines (Cerwenka et al., 2000 and Diefenbash et al.,
2001). Tumor cells avoid NK-mediated killing via NKG2D receptor, by shedding of
NKG2D ligand from their surface. Indeed, high levels of soluble MIC proteins were
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detected in sera of cancer patients (Grosh et al., 2002). In addition, tumors upregulate
TGF-β (a known immunosuppressive factor) that might induce downregulation of
NKG2D receptor on lymphocytes (Castriconi et al., 2003).
The NCRs are highly conserved among species even at the level of their cellular
ligands (Moretta et al., 2002). The only functional NCR homolog expressed in mice is
the murine NKp46 (NCR1) (Biassoni et al., 1999). NCRs are preferentially expressed on
NK cells and induce NK cytotoxicity upon cross-linking by specific monoclonal
antibodies. A functional crosstalk between the three NCRs was suggested since upon
ligation of a single NCR also induces signaling cascades of other NCRs (Augugliaro et
al., 2003). Accumulating evidence suggested that NCRs have important roles in
recognition and killing of tumor cells. NCRs blocking prohibited NK-mediated killing of
many tumor cell lines and in vivo, downregulation of NCRs or their ligands in acute
myeloid leukemia cells rendered them resistant to NK cytotoxicity (Biron et al., 2001 and
Costello et al., 2002).
NKp46 is the first identified member of NCRs (Sivori et al., 1997). NKp46 is
specifically expressed on NK cells, and a minor population of innate lymphoid cells
(Gazit et al., 2004). NKp46 cross-linking induced calcium mobilization, cytotoxicity and
cytokines release (Sivori et al., 1997). Upon engagement, NKp46 is associated with the
adaptor molecules CD3ζ and FcуR, which have the activation ITAM motif (Pessino et
al., 1998 and Falco et al., 1999). In humans, NKp46 is a 46KDa glycoprotein with two
Ig-like extracellular domains and three potential glycosylation sites located at positions
Thr125, Asp215 and Thr225 (Pessino et al., 1998). The membrane proximal domain of
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NKp46 is sufficient for the binding of NKp46 to tumor cells. However, it has been
suggested that the membrane-distal domain of the receptor is dispensable for its
function (Arnon et al., 2004). Recently, it was reported NKp46 and NKp30 involve
heparin sulfate in the recognition of tumor cells (Bloushtain et al., 2004). In addition, it
has been shown that high cell surface heparanase (heparin sulfate degrading enzyme),
or low heparin sulfate expression on tumor cells, rendered them less susceptible to NKmediated killing. Similarly, the absence of heparin sulfate expression reduced NK
mediated lysis (Bloushtain et al., 2004).
NKp44 encodes a 44 KDa surface glycoprotein. Antibody blocking of NKp44
partially inhibited cytotoxicity against NK susceptible targets (Vitale et al., 1998).
However, simultaneous blocking of both NKp44 and NKp46 led to a significant inhibition
of NK cells activity (Vitale et al., 1998), suggesting a functional cross talk among these
receptors (Augugliaro et al., 2003). In contrast to other NCRs, NKp44 is not expressed
on resting NK cells, but it is upregulated in response to IL-2 activation in vitro (Vitale et
al., 1998). In vitro upregulation of NKp44 by IL-2 may explain the enhanced cytotoxicity
of IL-2 activated NK cells towards non-MHC restricted targets. Very little information is
known about the cellular ligands of NKp44. The only identified ligand for NKp44 so far is
the hemagglutinin (Arnon et al., 2001).
NKp30 was shown to synergize with NKp46 and NKp44 to enhance cytotoxicity,
however, it also induces killing of targets that are NKp46/44-independent (Pessino et
al., 1998 and Moretta et al., 2000). NKp30 is expressed on resting as well as activated
NK cells (Moretta et al., 2000). NK cells incubation with TGF-β1 reduces NKp30
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cytolysis activity suggesting a possible mechanism by which tumor cells that produce
TGF-β evade NK response (Castriconi et al., 2003). NKp30 was also suggested to
interact with cell surface heparin sulfate as a co-receptor (Bloushtain et al., 2004). The
identified ligand for NKp30 so far is the HCMV tegument protein, pp65 (Arnon et al.,
2005).
5.5 NK Cells in Anti-Tumor Defense Mechanisms
The evidence for NK cells role in tumor clearance came from the ''missing self''
hypothesis when the MHC class I negative RMA-S cell line was rejected while the same
parental (positive for MHC class I) was not (Karre et al., 1986). In vivo deficiency
studies supported NK-dependent rejection of many tumor cell lines (Kim et al., 2000).
NK rejection of tumors was shown to be dependent on perforin (Van den Broek et al.,
1995 and Smyth et al., 1999), IFNγ (Straat et al., 2001) and TNF-α (Smyth et al., 1998).
The molecular mechanisms by which NK cells execute their antitumor effect is not
completely defined. Chronic DNA damage response in tumors results in upregulation of
NKG2D ligands suggesting a central role for this receptor in tumor control (Gasser et
al., 2005). NKG2D was also shown to play an essential role in tumor metastasis (Smyth
et al., 2005). NCRs are also crucial for the killing of tumors by NK cells since NKp46
blocking in vivo inhibited the NK anti-tumor response toward some melanoma cell lines
(Pessino et al., 1998). In addition, deletion of the mouse NCR gene in mice diminished
the ability of NK cells to eliminate tumors (Gazit et al., 2004). Recently, NK cells were
shown to modulate the innate and adaptive immune response. Active NK cells are
known to secrete IFNγ, which modulates downstream immune responses (Biron et al.,
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2001). When IFNγ released into tumor-drained lymph nodes by NK cells it primes a Th1
response. Naive T helper (Th) cells are activated by recognition of antigens presented
on antigen-presenting cells (APCs) by the interaction with the T-cell receptor (TCR).
Upon activation, these effector Th cells can be divided into three main types: Th type-1
(Th1); Th type-2 (Th2); Th type-17 (Th17) cells, with unique characteristics for each
type. Th1 cells secrete interferon (IFN)-γ, and (TNF)-β, which is critical for development
of cell-mediated immune response and consequently tumor cells elimination (MartinFontecha et al., 2004). It was shown that NK cells could behave like APCs through
antigen uptake and presentation to CD8 T cells (Hanna et al., 2004). In 1999, a report
showed an interaction between NK cells and DCs (dendritic cells) in anti-tumor
response (Fernandez et al., 1999). NK cells can activate DCs in the presence of TNF-α
(Piccioli et al., 2002). In addition, NK cells induce maturation of DCs in vivo, which
activates CD8+ T cells generating an anti-tumor response (Mocikat et al., 2003). These
observations suggest that NK cells mediate its anti-tumor role through two independent
effector and helper pathways.
5.6 Cancer Immunoediting
Cancer is a multistep process that represent dysregulation of both oncogenes
and tumor suppressor genes. Transformed cells acquire genetic and epigenetic
changes that contribute to the tumor phenotype. In order for normal cells to become
malignant they exhibit six alterations in their physiology which include; (1) selfsufficiency in growth signals, (2) insensitivity to antigrowth signals, (3) limitless
replicative potential, (4) evasion of apoptosis, (5) sustained angiogenesis (6) tissue
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invasion and metastasis, (7) reprogramming of cellular energy metabolism, (8) evasion
of the immune system (Douglas et al., 2011). The ability of the immune system to detect
and eliminate transformed cells is known as immunosurveillance. Ehrlich’s first
introduced the concept of immunosurveillance in 1909, when he demonstrated the
ability of the immune system to identify and destroy tumor cells. Ehrlich’s observation
was supported 50 years later by Burnet and Thomas when they suggested that
lymphocytes were responsible for the eradication of continuously arising tumor cells
(Burnet et al., 1970). Since then a lot of research has been done using a variety of wellcharacterized gene-targeted mice, specific immune system activators, and blocking
monoclonal antibodies highly specific for distinct immunologic components, to identify
components of the immune system that indeed protect the murine host against tumors
which include for example IFNγ and effector lymphocytes (T, NK and NKT cells).
Although the evidence for immunosurveillance depends mainly on mouse models, there
is evidence that humans also exhibit cancer immunosurveillance. For example, during
transplantation the immune system of the patients must be suppressed, which results in
more susceptibility to non-viral cancers. Birkeland et al. showed increased cancer
incidence for colon, lung, bladder, kidney, ureter, and endocrine tumors in 5692 renal
transplant patients (Birkeland et al., 1995). In addition, tumor-infiltrating lymphocytes
(TILs) is a predictor of patient’s five-year survival. Balch et al. analyzed Tumorinfiltrating lymphocytes from 120 different human cancers, including breast cancer, renal
cell carcinoma, melanoma, sarcoma, and colon cancer (Balch et al., 1990).
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Based on the above, immunosurveillance is a multifactorial process that requires
the actions of different immune effectors and this diversity is dependent on the tumor's
type, anatomic localization, tumor stage, tumor’s acquired genetic and epigenetic
changes, and immunological recognition pattern. Therefore, the immune system could
promote or eradicate tumors, which is described by a new term, immunoediting.
Immunoediting could result in (i) Elimination - This phase represents the ability of the
immune system to eradicate the developing tumor (Figure 5.2).
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Figure 5.2: A Cartoon Illustrates the Three Phases of the Cancer Immunoediting Process.
Normal cells (gray) are transformed to tumor cells (red) (top). In the elimination phase, cells and
molecules of innate and adaptive immunity, may eradicate the developing tumor. However, if elimination
fails, the tumor cells may enter the equilibrium phase where they may be either maintained chronically or
edited by the immune system to produce tumor variants that may eventually evade the immune system by
a variety of mechanisms and enter the escape phase (Dunn et al., 2004).
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The elimination phase is initiated by disruption of tissue surrounding the tumor
because of invasive growth and angiogenesis (Hanhan et al., 1996, Carmeliet et al.,
2000 and Sternlicht et al., 2001). Stromal remodeling is accompanied by proinflammatory cytokines and chemokines production to recruit immune effector cells such
as NK, T, NKT and /or macrophages to tumor site. The recruited immune cells are
activated once they recognize their cognate ligands and secrete cytokines such as
IFNγ, IL-2 and IL-12 that amplify the signal and recruit more CTL to tumor site (HodgeDufour et al., 1997). IFNγ can enhance the expression of tumoricidal products by
macrophages, enhance NK cytotoxic function toward tumor cells and /or kill tumor cells
by anti-proliferative, pro-apoptotic and angiostatic effects (Luster et al., 1993, Coughlin
et al., 1998 and Qin et al., 2000). Dead tumor cells, in turn, become a source of
antigens that could be directly cross-presented by DC to CD4 Th1 T cells to develop
tumor specific CD8 T cells (Albert et al., 1998).
(ii) Equilibrium - In the equilibrium phase the tumor cells which survived
the elimination phase enter a dynamic equilibrium with immune cells that exert selection
pressure on these genetically unstable tumor clones. This phase is the longest of the
three phases and it might take years for tumor cells in equilibrium to generate clones
that are poorly recognized either by the immune system or that have acquired
mechanisms to suppress immune effector functions (Loeb et al., 2005). (iii) Escape - In
this phase, tumor cells at equilibrium acquire genetic and/or epigenetic modifications to
avoid the immune system detection and elimination. Mechanisms of evasion include
release of immunosuppressive factors such as TGF-β (Sakaguchi et al., 2001), induce
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infiltration of regulatory T cells (Khong et al., 2002), antigenic drift, loss of MHC
components (Marincola et al., 2000), shedding of ligands that induce cytotoxic activity of
CTL (Groh et al.,2002) and /or development of IFNγ insensitivity (Kaplan et al., 1998).
These mechanisms reflect how tumor cells can be edited by the immune system.
5.7 Breast Cancer & Immunoediting
Breast cancer is the most common cancer in women, approximately one in eight
women developing breast cancer during their lifetime. Breast cancer is a heterogeneous
disease with multiple subtypes and diverse histopathology that results in different
clinical outcomes (Rosen et al., 2007). Tumor histological grade and tumor type are the
most important tumor characteristics that can be estimated by histopathological analysis
of breast cancer. There are many types of breast cancer which include
adenocarcinomas, micro-papillary, metaplastic, medullary carcinomas and
inflammatory. Tumor grade is an evaluation of the degree of differentiation, proliferative
capacity that indicates the tumor's aggressiveness (Elston et al., 1991). Normal breast
structure is composed of two epithelial layers, the inner luminal epithelium from which
luminal epithelial breast cancer is derived and the outer basal epithelial layer from which
the basal-like breast cancer originates. The confinement of breast cancer to breast
ducts or lobes is referred to as DCIS (ductal carcinoma in situ) and LCIS (lobular
carcinoma in situ) (Li et al., 2006). Breast cancer can be further classified into subtypes
based on the incorporation of molecular markers of prognosis and recurrence such as
ER, PR, Her/2neu and p53 (Silverstein et al., 1995).
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There is evidence for immunosurveillance in breast cancer supported by the
presence of CD4, CD8, CD20 and NK cells in DCIS lesions (Macchetti et al., 2006 and
Czerniecki et al., 2007). This suggest that these effector cells might infiltrate the tumor
to promote or eliminate the tumor. For example, breast tumors infiltrated with DCs that
express the CD83 (maturation marker) exhibit prolonged disease-free survival in those
patients (Czerniecki et al., 2007). However, the presence of CD4, CD8 positive T cells
or macrophages showed no prognostic significance. The infiltration rate of T cells into
tumors of patients with lymph node positive breast cancer was significantly increased
relative to those without lymph node metastases (Macchetti et al., 2006). Similar to
mouse studies (Knutson et al., 2006 and Santisteban et al., 2009) the presence of CD8
T cells in human breast cancer has not shown an association with increased survival.
Some studies showed that increased tumor grade and Ki-67 staining (a marker of
proliferation) were associated with increased infiltration of CD8, CD4, tumor-associated
macrophages, and increased tumor angiogenesis. These results could be explained by:
(i) the active immune response toward poorly differentiated tumors increases tumor
proliferation, angiogenesis, and dissemination; (ii) high grade tumors secrete many
cytokines in the tumor microenvironment, which attracts immune cells and increases
microvessel density (Murri et al., 2008 and Matkowski et al., 2009). Collectively, the
tumor immunogenicity and its microenvironment will likely dictate the type of infiltrating
immune cells and their function whether to promote a tumor or impede it.
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5.8 The NURF Complex
5.8.1 The Three Main Subunits of NURF Complex and Their Role in Cancer.
The NURF complex is a member of ISWI family and consists of the three main
subunits: bromodomain PHD-finger containing transcription factor (BPTF); the ISWI
ATPase SNF2L; the WD repeat protein pRBAP46/48 (Xiao et al., 2001and Barak et al.,
2003). BPTF is the unique and largest subunit of NURF complex and it is crucial for the
maintenance of complex integrity (Xiao et al., 2001). BPTF contains several conserved
domains that form platforms for recruitment of modified histones, transcription factors
and other NURF subunits, which include DDT domain, PHD finger, WAC and WAKZ in
the N-terminal domain. The DDT domain interacts with the slide domain and this
interaction is essential for maintaining the complex integrity (Xiao et al., 2001). The
BPTF subunit has two PHD domains as mentioned above, which has Cys4HisCys3 (4
cysteines a histidine and 3 cysteines). The C-PHD domain strongly interacts with
H3K4me3 or 2 while it interacts weakly with H3K4me1 (Wysocka et al., 2006). The
bromodomain binds acetylated histones (H3K16ac) and cooperate with the C-terminal
PHD which binds H3K4me3 to facilitate NURF localization to sites in chromatin with
modified histones (Ruthenburg et al., 2011).
SNF2L is essential for both catalytic and remodeling functions of the NURF
complex. The N-terminal domain of SNF2L includes ATP binding domain and helicase
domain. The ATP binding domain is enriched with acidic residues that interact with the
positive residues in the N-terminal tail of H4 to facilitate the NURF remodeling activity
(Mueller et al., 2013). The C-terminus of SNF2L has three domains, HAND, SANT
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(Swi3 Ada2-N-cor TfIIIB) and SLIDE (Sant like Domain) (Clapier and Carins et al.,
2009). The HAND domain is required for the interaction with the nucleosomal DNA
(Dang and Bartholomew 2007). The SANT domain is believed to enable the NURF
complex to interact with histone H3 (Boyer et al., 2004). The SLIDE domain interacts
with nucleosomal linker DNA and this interaction is required for the complex remodeling
activity (Hota et al., 2013).
RbAp46 and RbAp48 are homologous proteins with WD (Tryptophan-Asparatic)
repeats that form the platform to facilitate protein-protein interactions to tether the
remodeler complex to its chromatin. Both proteins act as histone chaperones for histone
deposition into nucleosomes. RbAp48 interacts with H3-H4 dimer to mediate its
incorporation into assembled nucleosomes (Zhang et al., 2013). For example, the
interaction between RbAp46/48 and the transcription factor FOG1 (Friend of Gata1)
recruit the NURD complex to specific sites of chromatin (Hong et al., 2005). Both
proteins are also involved in cancer. Overexpression of the RbAp46 in the human
breast epithelial cells, MCF10AT3B, induced suppression of cell growth in vitro and
reduced tumor formation in vivo (Li et al., 2003). Similarly, knockdown of the RbAp48
protein in the cervical cell line, H8, induced tumor formation in nude mice through the
control of the HPV16 transforming activity (Kong et al., 2007).
5.8.2 NURF Remodeling Activity
As mentioned above, NURF complex subunits involved in protein-protein
interactions which facilitate the complex remodeling activity by its recruitment to
nucleosomes. Upon NURF recruitment, it binds the nucleosome at two separate sites,
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at linker DNA beside the entry site, and the nucleosomal DNA at the exit site. After
binding, the NURF complex utilizes ATP hydrolysis to move nucleosomes ~ 10bp in
either direction (Schwanbeck and Wu 2004). The remodeling activity of NURF can be
regulated by many mechanisms, which include: incorporation of a SNF2L variant that
produce non-functional ATPase (Barak et al., 2004) or PTM of the NURF complex
reduces its remodeling function. For example, ISWI acetylation by the histone acetyl
transferase GCN5 has been thought to reduce the complex remodeling activity (Ferreira
et al., 2007). In addition, the composition of the histone octamer and nucleosome
structure can modulate the NURF activity. For example, the incorporation of the histone
variant H2AZ enhances ATP hydrolysis ~9 fold greater than H2A and increases its
remodeling activity (Goldman et al., 2010). Collectively, the NURF remodeling activity is
affected by incorporation of an inactive ATPase, histone variants or the PTM of the
complex (Alkhatib and Landry, 2011).
5.8.3 The Biological Roles of NURF Complex
The NURF complex interacts with many transcription factors and DBPs with
consequences on gene expression and function (Xiao, et al. 2001). In Drosophila,
NURF is required for the expression of homeotic genes and its disruption affects the
determination of body segments (Badenhorst, Voas, et al. 2002). In addition, NURF is a
co-activator of the Wingless pathway through its interaction with the pathway signal
transducer β-Catenin/Armadillo, which is a transcription factor that recruit NURF to
promoters of Wingless downstream genes to initiate their expression (Song, SpichigerHaeusermann and Basler 2009). NURF is essential for self-renewal and maintenance of
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germline stem cells through its positive regulation of the JAK/STAT pathway (Cherry
and Matunis 2010). In human breast cancer cell lines, BPTF interacts directly with PR
(progesterone receptor) to recruit NURF, which in turn recruits other co-activators to
promote gene expression (Vicent, et al. 2011).
As a chromatin remodeler, NURF is involved in the regulation of the chromatin
structure. NURF directly interacts with the histone chaperone Nap1 to regulate
nucleosomes assembly at heterochromatin domains (Stephens , et al. 2006). NURF is
also, involved in the separation between euchromatin and heterochromatin regions. In
chicken erythroleukemia cell lines USF1 interact with NURF to mediate its recruitment
to the HS4 element of the β-globin insulator. HS4 element is required to prevent the
heterochromatin from disrupting β-globin locus expression (Li, et al. 2011). In addition,
recent work in our lab supports the role of NURF in regulation of chromatin structure.
CTCF is the main insulator in vertebrates with roles in chromatin looping to enhance
gene expression like the ring-like structure cohesion. Insulators are DNA-protein
complexes, which prevent enhancer-promoter interactions and/or form barriers to
isolate the silencing effects of heterochromatin (Jingping et al., 2011). NURF interacts
with both CTCF and cohesion suggesting a possible role in chromatin looping and
organization (Qiu, et al. 2015).
In mammals, NURF is essential for early embryonic development since KO of
the complex’s essential subunit (BPTF) resulted in early embryonic lethality. BPTF KO
embryos fail to gastrulate due to defective DVE differentiation, which could be due to its
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co-activation role of the TGF/Smad pathway. Moreover, BPTF KO mESCs were
defective in their differentiation potential, which is supported by the defective
differentiation of embryoid bodies and teratoma in vitro (Landry et al., 2008). This
observation was further verified by investigating the role of NURF in T cell development.
Thymocyte maturation is accomplished by TCR (T-cell receptor) pathway to determine
the lineage specification of a double positive cell that express both CD8 and CD4 to be
a single positive cells that express CD8 or CD4. Thymocytes isolated from BPTF KO
mice exhibited normal proliferation rate but fail to specify their lineage, which suggest
the NURF role as cell type-specific regulator of gene expression (Landry, et al. 2011).
5.8.4 NURF and Cancer
BPTF and by extension NURF is located on chromosome 17 at q24.2, this region
is amplified in many cancers including neuroblastoma (Bown, et al. 1999), breast
cancer (Monni, et al. 2001), prostate cancer (Levin, et al. 2008), liver cancer (Raidl, et
al. 2004) and lung cancer (Choi, et al. 2006), which suggest advantageous role for this
region to tumor survival. BPTF overexpression is associated with more aggressive
disease in HCC (hepatocellular carcinoma) and colorectal cancer (Xiao, Liu and Fang,
et al. 2015). BPTF overexpression in melanoma is associated with poor prognosis, in
addition, KD of BPTF reduced proliferation rate of melanoma cell lines both in vitro and
in vivo (Dar, et al. 2015). C-myc is a proto-oncogene that is deregulated in many
cancers (Vita et al., 2006). Recently, Richart et al. showed that BPTF is a co-partner of
c-myc to regulate the transcription program of c-myc in MEFs and in vivo depletion of
BPTF reduced tumor growth (Richart et al., 2015). Recent work in our lab revealed that
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BPTF knock-down enhance tumor immunogenicity by directly regulating the
immunoproteasome subunits Psmb8 and Psmb9, Tap1 and Tap2, which enhance
antigen presentation and production (Mayes et al., 2016).
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Chapter 6
Material and Methods
6.1 Cell Culture
67NR, 66cl4, 4T1 (Fred Miller, Wayne State University) and SY5Y, HeLa, HEK
293T (ATCC) were cultured in DMEM (Thermo-Fisher), 10% FBS (Hyclone), 1% NEAA
(Thermo-Fisher), 1% glutamine (Thermo-Fisher), and 1% penicillin/streptomycin
(Thermo-Fisher). T47D and MDA-MB-436 were cultured in RPMI (Thermo-Fisher), 10%
FBS, 1% NEAA, 1% glutamine, 1% penicillin/streptomycin and 5 µg/ml insulin (Sigma).
NK-92 cells (ATCC) were cultured in Alpha MEM (Thermo-Fisher), 12.5% horse serum
(Sigma), 12.5% FBS, 2 mM L-glutamine, 1.5 g/L sodium bicarbonate (Sigma), 0.2 mM
inositol (Sigma), 0.1 mM β-mercaptoethanol (Sigma), 0.02 mM folic acid (Sigma) and
200 U/ml Il-2 (R&D Systems). OT1 T cells were cultured in DMEM containing 10% FBS,
1% NEAA, 1 % glutamine, 1% penicillin/streptomycin, 1% HEPES (Thermo-Fisher), 50
µM β-mercaptoethanol and 500 U/ml mouse IL-2.
6.2 Western Blotting
Monolayer cells, cell pellet or collected tumors homogenate were homogenized
by pipetting using 1 ml pf TRI-Reagent for 5 min. The homogenates were incubated with
200 μl chloroform for 15 min. Then, samples were centrifuged for 15 min at 20,000 RCF
at 4°C. Three layers were formed; an aqueous phase contains the RNA, an interphase
contains the DNA and an organic phase contains the proteins (bottom layer). After
removing the aqueous and interphase, 1 ml isopropanol was added to samples and the
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tubes were incubated at room temperature for 10 min. Then, the samples were
centrifuged at 20,000 RCF for 15 min at 4°C. The supernatants were discarded and 1
ml of 0.3 M guanidine in 95% ethanol was added for overnight wash at 4°C on shaker.
Then, the guanidine was removed by centrifugation at high speed and protein pellets
were washed overnight with 1 ml of 100 % ethanol at 4°C on shaker. Next, proteins
were dissolved in 250 μl of 8 M urea in 1% SDS at 65°C overnight. Protein
concentration was measured using Bio-Rad Dc Protein Assay provided by Bio-Rad
Laboratories (Hercules, CA) using BSA standards. 50 μg of protein was loaded into 4%
SDS-PAGE, and run for 1 hour at 200 V and 300 mA. Next, proteins were transferred
into PVDF (polyvinylidene fluoride) membrane for 17 hours at 20 V and 30 mA. Transfer
buffer for Ino80 was 10 mM CAPS-NaOH [ph10.5] and 2.5 mM DTT. After transfer, the
PVDF membranes were blocked with 5% non-fat dry milk for 1 h, and incubated with
primary antibody for overnight at 4°C. Primary antibodies used in this study include;
BPTF (custom rabbit polyclonal) at 2 µg/ml; anti-heparanase (Santa Cruz Cat#
sc25826) at 1 µg/ml; anti-HS (Millipore Cat# MAB2040) at 2µg/ml. Next, membranes
were washed three times with PBST (phosphate buffer saline with 0.1% tween 20) for
10 min each, and the membranes were incubated with horseradish peroxidase (HRP)conjugated anti-rabbit or anti-mouse secondary antibody (Cell Signaling) at 0.1 µg/ml for
1hour. The plots were then washed for 10 min with PBST for three times and developed
using Super Signal West Femto Substrate (Thermo Scientific).
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6.3 BPTF KD (in OT1 & NK Cells Using Replication-Deficient Adenovirus)
Spleens from OT-l mice were harvested and dispersed into single cell
suspensions in MACS buffer and erythrocytes were removed by suspension in RBC
lysis buffer. The cells were then washed, suspended in DMEM containing 10% FBS, 1%
NEAA, 1% glutamine, 1% penicillin/streptomycin, 1% HEPES, 50µM β-mercaptoethanol
(Sigma) and 500 U/ml mouse IL-2 (R&D Systems), and co-incubated with mitomycin Ctreated B16F10-OVA cells for 3 weeks with continuous medium change until we got a
high population of OT1 T cells. 3X106 NK-92 or 5X105 OT1 T cells were infected with
2X107 rADV or 2X106 in a volume of 10 ml or 1 ml for 5 days and then collected for
Western blot analysis. Remaining cells were used for cytotoxicity assays as described
below.
6.4 Tumor Studies
1x105 67NR cells, 1x104 66cl4 cells or 1X105 4T1 cells were injected into the
fourth mammary fat pad of BALB/cJ or NSG mice. Tumors were analyzed at 21 days
(67NR), 28 days (66cl4) or 35 days (4T1). For rADV studies, BALB/cJ mice were
inoculated with 1x106 66cl4 or 3x105 4T1 cells and injected intratumorally with rADV-Luc
or rADV-BPTF (1 × 109 PFU in 100ul) every 3 days for 3 weeks once tumors were ~5
mm in any dimension. Animals were euthanized 1 week after the last injections and
tumors were collected for analysis. For all 4T1 studies, mice were injected I.P. with 1.2
mg/mouse gemcitabine 5 days after tumor inoculation and once every 7 days thereafter.
The mice used in these studies were BALB/cJ (Jackson Laboratories Cat# 000651) and
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NOD/SCID/Ifrg2r -/- (NSG) (Jackson Laboratories Cat# 005557) female mice 6-8 weeks
of age were housed under aseptic barrier conditions. The Institutional Animal Care and
Use Committee at Virginia Commonwealth University have approved these studies.
6.5 Mouse NK Cells Purification
The spleens of BALB/c mice and NK cells were purified by negative selection
using a magnetic separation MACS column (Miltenyi Biotech, cat# 130-690-864.). The
spleens were cut and pressed gently to release the splenocytes. The splenoctytes were
collected with 5 ml of MACS column buffer (PBS [pH 7.2], 2 mM EDTA, 0.5% BSA) and
passed through a 0.45 μm filter to create a single cell suspension. The cells were
counted and centrifuged for 10 min at 300 x g before resuspending into 400 μl of buffer
per 1 x 108 cells. 100 μL of a primary biotin-conjugated antibody cocktail (Miltenyi
Biotec) was added per 1 x 10^8 cells and incubated on ice for 20 min. This cocktail
binds all non-NK cells. 300 μL of buffer was subsequently added followed by 200 μL of
secondary magnetic microbead-strepavidin antibody per 1 x 108 cells and incubated for
10 min on ice. The samples were then washed with 4 mL of buffer per 10 8 cells and
centrifuged for 10 min at 300 x g. After carefully aspirating the supernatant, the cells
were resuspended into 500 μL of buffer per 1 x 108 cells and separated on MACS LS
columns (Miltenyi Biotec). The LS columns pre-rinsed with 3 mL of buffer before adding
500 μL of the prepared splenocytes suspension. Following this, 3 mL of buffer was
added to the column to elute the unlabeled NK cells, while the column retained the
biotin-labeled cell fractions. NK cells were eluted using three additions of buffer. The
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eluted NK cells were centrifuged for 10 min at 300 x g and resuspended into 2 mL of
complete RPMI-10 medium (10% FBS, 2 mM glutamine, 1x penicillin-streptomycin, 50
μM β-mercaptoethanol and 50 U/ml IL-2) and counted.
6.6 NK Cell Cytotoxicity Assay
NK 92 cells were cocultured with the targets, which were plated at the indicated
E:T ratios for 4 hrs. For antibody blocking experiments, NK cells were pre-incubated for
1 hr with blocking antibodies to hNKp46 (Biolegend Cat# 13614), hNKp30 (Biolegend
Cat# 325204) or hNKG2D (BD Pharmingen Cat# 552866) at 10 µg/ml. NK cells were
then plated on mitomycin C treated cells for assay. Cell death was measured using the
CytoTox 96® Non-Radioactive Cytotoxicity Assay (Promega). The plate was then
placed on a plate reader and the wells were read at 490 nm absorbance for LDH
release by spectrophotometer (Synergy H1 Multi-Mode Plate Reader, BioTek). Percent
cytotoxicity was calculated using (Experimental – Effector Spontaneous – Target
Spontaneous)/ (Target Maximum – Target Spontaneous) x 100.
6.7 Flow Cytometry
To measure NK activity, purified mouse splenic NK cells were incubated with
mitomycin C treated cells for 24 hours. NK cells were removed and stained with BD
Pharmagen antibodies; 0.25 µg anti-NKp46 (FITC), (Cat# 137605); 0.1 µg anti-CD69
(PE), (Cat# 561932) and 7AAD viability dye.
For tumor infiltrating lymphocyte analysis, tumors were minced and digested in
0.04% DNase 1, 0.1% collagenase IV (Sigma) at 37°C for 30 min. Tumor digests were
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filtered with a 40 µM nylon filter and centrifuged at 500 x g for 5 min at room
temperature. Cells were resuspended in 40% percoll (Sigma), layered on top of 70%
percoll and centrifuged at 3000-x g for 30 min at room temperature. Lymphocytes at the
interphase were removed, diluted in PBS, and centrifuged at 500 x g for 5 min at room
temperature. Cells were stained with BD Pharmagen antibodies: 0.25 µg anti-NKp46
(FITC), (Cat# 137605); 0.1 µg anti-CD69 (PE), (Cat# 561932); 0.25 µg anti-CD3 (PE),
(Cat# 553060); 0.25 µg anti-CD8 (FITC), (Cat# 100706) antibodies and 0.5 µg 7AAD
viability dye.
For the Ncr1-Ig fusion protein was purified by protein G chromatography from
the culture supernatant of stably transfected HEK293 cell line (gift from Ofer
Mandelboim). 1X105 Cells were incubated with 5 µg of the soluble receptor for 45min at
4°C, washed, stained with PE- anti-Human-IgG Fc (Biolegend Cat# 409304) for 20 min
and analyzed by flow cytometry using a FACS Calibur flow cytometer (Becton
Dickinson).
6.8 Enzyme Linked Immunosorbent Assay (ELISA)
Tumors were minced with a clean razor blade and placed in HBSS supplemented
with complete protease inhibitor (Roche). After 3 of freeze-thaw cycles, samples were
centrifuged at 15000 x rpm at 4°C for 15 min supernatant was collected and tested for
total protein using a DC protein assay kit (Biorad). ELISA for IFNγ was performed
according to the manufacturer's instructions (R&D systems). IFNγ concentrations was
then normalized to total protein.
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6.9 Ncr1- ζ Chain Reporter Assay
Murine BW thymoma cells (TCR α/β negative) were transfected with constructs
encoding chimeric proteins in which the extracellular portion, which has the ligand
binding domain of NKp46 is fused to the transmembrane and tail domains of the
CD3 ζ chain. The cytoplasmic domain of the T-cell receptor ζ-chain is sufficient to trigger
IL-2 secretion upon ligation of extracellular portion of NKp46 to its cognate ligand (Gili et
al., 2009). To measure the levels of NCR1 and its ligands expressed by target tumor
cell lines, BW Ncr1-ζ and target cell lines were co-incubated at 1:1 E: T ratio for 48 h at
37°C and 5% CO2. Total RNA was extracted from cultured cells with TRI Reagent and
5 µg RNA was reverse transcribed using Superscript II First-Strand Kit (Invitrogen).
qRT-PCR was performed using SYBR green PCR master mix (Biorad) with a 7900 HT
Fast Real-Time qPCR System (Applied Biosystems). The ∆∆CT method was performed
using normalization to GAPDH. Primer pairs are provided in Table 6.1

Table 6.1: Primers Used for IL-2 qRT-PCR
NCR1-Zeta IL2 Reporter Assay Primers
NCR1
For GAGGATCAACACTGAAAAGGAGAC
Rev ACTCTGCTTGGATGTTCCCA
IL- 2
For CCTGAGCAGGATGGAGAATTACA
Rev TCCAGAACATGCCGCAGAG

6.10 qRT-PCR
qRT-PCR was performed as described in chapter two. Primers used for heparanase
quantification are provided in Table 6.2.
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Table 6.2: Primers for Heparanase Quantification
Heparanase qRT-PCR Primers
mGapdh
mHeparanase (67NR)
mHeparanase (66cl4)

For TGGCAAAGTGGAGATTGTTGCC
Rev AAGATGGTGATGGGCTTCCCG
For GAGCGGAGCAAACTCCGAGTGTATC
Rev GATCCAGAATTTGACCGTTCAGTT
For GGAAATCTCAAGTCAACCATGATAT
Rev ATCTCCACTGAGCTTCTTGAGTAG

6.11 Chromatin Immunoprecipitation (ChIP)
ChIP was performed as described in chapter two and primers used for
heparanse promoter are provided in Table 6.3.

Table 6.3: Primers for Heparanae ChIP Analysis
Heparanase ChIP Primers
Promoter Site

For GGTGGCCAGAATCCAAGATCC
Rev AAAAACAGGGTCCCCACCAC

6.12 Statistics
Standard deviation was used to calculate error bars throughout the study. P
values were calculated using two tailed T tests. Number of replicates are designated in
the repetitive figure legends.
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Chapter 7
Results

7.1 BPTF Depletion in Tumors Enhances NK Cell Antitumor Activity
To uncover the possible role for BPTF in breast cancer biology, we transduced
the well-established 67NR and 66cl4 mouse breast cancer cell lines (Aslakson and
Miller, 1992) with retroviruses expressing control (Ctrl-sh1, Ctrl-sh2) or BPTF (Bptf-sh1,
Bptf-sh2) short hairpin RNAs (Figure 7.1 A). Both Ctrl and BPTF KD 66cl4 and 67NR
cell lines were inoculated into the 4th mammary fat pad of syngeneic BALB/c mice and
tumors were collected 3-4 weeks later and tumor weights were assessed. We observed
a significant reduction in BPTF KD tumor weight compared to controls (Figure 7.1 B).
Microarray analysis of control and BPTF KD tumors discovered an enrichment of genes
with gene ontology (GO) terms that included immune response genes (data not shown)
suggesting a possible role for the immune system in the BPTF KD reduced tumor
weight. To validate our hypothesis, we have inoculated both Ctrl and BPTF KD 66cl4
and 67NR cell lines into an immune-deficient NOD/SCID, Ifrg2r -/- (NSG) background.
Both Ctrl and BPTF KD 66cl4 and 67NR cell lines showed equivalent tumor weights to
controls, suggesting an immune response toward BPTF KD tumors (Figure 7.1 C).
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Figure 7.1: NK Cells Are the Key Effectors in BPTF KD 67NR and 66cl4 Tumor Weight Reduction.
A) BPTF Western blot analysis from control (Ctrl-sh1, Ctrl-sh2) and BPTF KD (Bptf-sh1, Bptf-sh2) 67NR
and 66cl4 total cell extracts. Membranes were stained with Ponceau as a loading control.
B) 67NR and 66cl4 tumor weights harvested from BALB/c mice. Control and BPTF KD cells were injected
subcutaneously into the fourth mammary fat pad of BALB/c mice and tumors were weighed on day 21
(67NR) or day 28 (66cl4) (n ≥ 11, * = t-test p-value < 0.0005).
C) 67NR and 66cl4 tumor weights harvested from NSG mice (n = 9).
D&E) 67NR and 66cl4 tumor weights harvested from undepleted, or CD8+, CD4+ or asialo-GM1+ mAb
depleted BALB/c mice (n = 6, * = t-test p-value < 0.05).
This figure is done by Suehyb Alkhatib and Kimberly Mayes.
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The immune system executes its elimination function against tumors using
immune effector cells. These immune effector cells infiltrate the tumor tissue to lyse
tumor cells. Lymphocytes populations have been identified in breast cancer, which
include (CD8+) T cells, helper (CD4+) T cells and NK cells (Whitford et al., 1992 and
Chin et al., 1992). To characterize the main effector immune cells that are involved in
BPTF KD reduced tumor weights, we depleted the major immune effector cells in mice
that have been inoculated with both Ctrl and BPTF KD 66cl4 and 67NR cell lines using
monoclonal antibodies against NK cells, CD8+ T cells, or CD4+ T cells. Depletion of
CD8+ T-cell or CD4+ T-cell did not reduce the weight BPTF KD tumors (Figure 7.1 D,
E). However, NK cell depletion resulted in approximately equal tumors weight in both
Ctrl and BPTF KD 67NR and 66cl4 cell lines. These results suggest that NK cells are
the major effector immune cells that are responsible for the reduced BPTF KD tumor
weight.
To quantify and characterize the NK cell population in the tumor
microenvironment (TME), we have conducted flow cytometry analysis on lymphocytes
isolated from both Ctrl and BPTF KD 67NR and 66cl4 tumors. The gating strategy is
illustrated in (Figure 7.2 A, C). To evaluate the abundance of lymphocytes in the TME,
we stained lymphocytes with CD3 and NKp46 to select for the CD3- and NKp46+
population. We used the CD3 marker to exclude the NKT cell population that express
NKp46 on their cell surface. As shown in (Figure 7.2 B) the rate of NK cells infiltration
was very high in these tumors. To eliminate the possibility of non-specific staining, we
repeated the same experiment using 4T1 tumors that are known to be poorly infiltrated
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with NK cells (duPre et al., 2008). To assess the activation status of NK cells we used
CD69, a known marker for lymphocytes activation. As shown in (Figure 7.2 D), that NK
cell abundance in the TME was approximately equal in both Ctrl and BPTF KD 67NR
and 66cl4 tumors. However, NK cells in BPTD KD TME were more active than those in
Ctrl tumors (Figure 7.2 D). These results demonstrate that BPTF KD cells enhance NK
cytotoxic activity, which could result in the observed reduced tumor weight.
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Figure 7.2: NK Cells Are More Active in the BPTF Depleted Tumor Microenvironments.
A) Representative flow cytometry dot plots of live tumor infiltrating NK cells stained with CD3ε and NCR1.
B) Percentages of live CD3-, NCR1+ NK cells from of all live lymphocytes isolated from tumors (n ≥ 6).
C) Representative flow cytometry dot plots of live tumor infiltrating NK cells stained with CD69 and NCR1.
D) Percentages of live NCR1+ cells that are CD69high (n = 6, * = t-test p-value < 0.006).
This figure is done by Mark Roberts and Zeinab Elsayed.
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7.2 BPTF Depletion in Cancer Cells Enhances NK Cell Cytotoxic Activity in Vitro
Through NCR Receptors
The ability of NK cells to kill BPTF KD cells in vivo suggests that BPTF KD cells
are better targets than Ctrl cells for NK cells and enhance their cytotoxicity. To verify
this observation in vitro we cocultured the purified splenic mouse NK cells with both Ctrl
and BPTF KD 67NR and 66cl4 cells. Results showed that NK cells are more active
when cocultured with BPTF KD targets as was indicated by the elevated expression of
cell surface activation markers CD69 and NKp46 (Figure 7.3 A, B). The question now,
how BPTF KD targets enhance NK cytotoxic activity. The most likely explanation is that
BPTF KD cells overexpress or downregulate activating or inhibitory NK receptor ligands,
respectively. However, NK cells have a hundred of activating and inhibitory receptors,
which make it difficult to screen the ligands of all these receptors on the cell surface of
BPTF KD targets.
In an attempt to narrow down our possible ligands, we have tested the ability of
the human NK-92 cells to lyse both Ctrl and BPTF KD targets. NK-92 cells are IL-2dependent human cell line that expresses high levels of activating receptors (NKp30,
NKp46, 2B4, NKG2D and CD28), high levels of cytotoxic molecules such as perforins
and granzymes, and few inhibitory receptors (Guitta et al., 2000). The number of major
killing receptors that are involved in cancer elimination and conserved between NK-92
and naïve mouse NK cells are limited. Towards this end, we co-cultured our NK-92 cells
with both Ctrl and BPTF KD targets and measured the cytotoxic effect of NK-92 cells.
As illustrated in (Figure 7.3 C), NK-92 cells showed significantly more cytotoxic effects
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toward BPTF KD targets compared to controls. These same results were observed
using native mouse NK cells (data not shown). These results in combination suggest
that NK-92 cytotoxic activities toward BPTF KD targets is due to a conserved cell
surface receptor on both NK-92 and mouse naïve NK cells.
To identify the receptor on NK-92 which recognizes a BPTF-dependent ligand,
we have blocked the major activating receptors on NK-92 cells using monoclonal
antibodies against NKp46, NKp30 and NKG2D. The results showed that NKp30
blocking significantly diminished the NK-92 cytotoxic activity toward BPTF KD 66cl4
(Figure 7.4 A-C). NKp30 is highly expressed on NK-92 and it is also the major NCR
used by NK92 cells for antitumor activity (Maki et al., 2001). Also, NKp46 reduced NK92 cell activity but the results were not statistically significant. However, blocking of
NKG2D has almost no effect on NK-92 cytolysis. These results demonstrate that NCRs
are the major receptors involved in the killing of BPTF KD targets.
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Figure 7.3: A Cell Surface Factor Enhances Mouse NK Cells and NK-92 Cells Activation Toward
BPTF Depleted Tumor Cells.
A) Representative flow cytometry dot plot and percentages of live mouse NK cells stained with NCR1 and
CD69 after coculture with 67NR or 66cl4 targets at a 5:1 E: T ratio (n = 3, * = t-test p-value < 0.04).
B) Fold change of NCR1 MFI on mouse NK cells after co-culture with 66cl4 or 67NR target cells at a 5:1
E: T ratio. (n ≥ 4, * = t-test p-value < 0.05).
C) NK-92 cells were cocultured with 67NR and 66cl4 at the indicated E: T ratios (n = 3, * = t-test p-value <
0.05).

110

A

C

B

Figure 7.4: NKp30 is Required for BPTF KD Targets Killing by NK-92 Cells in vitro.
A) Cytolytic activity of NK-92 cells non-treated or pretreated with anti-NKp46 using the LDH assay,
B) Cytolytic activity of NK-92 cells non-treated or pretreated with anti-NKp30 using the LDH assay,
C) NK-92 cells non-treated or pretreated with anti-NKG2D mAb when cocultured with control or BPTF KD
66cl4 targets at a 10:1 E: T ratio (n = 3, * = t-test p-value < 0.05).

111

To verify our observation, we repeated our cytotoxicity assay in the presence of
heparin. Soluble heparin is known to inhibit NCRs binding to their ligands on tumor cells
and enhancement of NK cells activity. When BPTF KD targets cocultured with NK-92
cells in the presence of heparin, NK-92 cytotoxic activity was significantly reduced,
which further supports that NKp30 is the NK-92 receptor that enhances their cytolysis
activity toward BPTF knock-down targets (Figure 7.5 A, B).
NKp46, and its mouse orthologue NCR1, are important activation receptors that
are involved in the killing of tumor cells in vitro and in vivo (Sivori et al.,1999, Sivori et
al., 2000 and Gili et al., 2009). It has been shown that the proximal domain of NCR1 is
the ligand binding domain that activates NK cells degranulation upon engagement (Alon
et al., 2005). The fusion of this domain to the FC portion of the human IgG have been
widely used to identify the receptor ligands (Gazit et al., 2006).
In order to assess the levels of NKp46/NCR1 ligands on the surface of both Ctrl
and BPTF KD 67NR and 66cl4 cell lines, we stained cells with recombinant NCR1-Fc
receptor. Flow cytometry analysis revealed equal binding of NCR1 in both Ctrl and
BPTF KD cells (Figure 7.5 C). Based on cytotoxicity assay results that exhibited more
NK cytotoxic activity toward BPTF KD targets suggests the presence of more activating
ligand on BPTF KD targets. We explored the ability of both Ctrl and BPTF KD targets to
induce IL-2 expression in BW reporter cells.
The BW cells are a mouse thymoma cell line that lack the expression of α and β
of TCR chains and can be induced to secrete IL-2. When the NCR1 ligand binding
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domain is fused to the CD3-ζ chain and stably expressed in BW cells, the chimeric
protein can induce the expression of IL-2 upon ligand binding (Gili et al., 2009). As
shown in Figure 7.5 D, co-incubation of both Ctrl and BPTF KD target with BW cells
resulted in higher expression of IL-2 in BPTF KD targets, suggesting the presence of a
functional NCR1 ligand on the cell surface of BPTF KD cells.
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Figure 7.5: NK Cell Cytolysis Activity to BPTF KD Cells Requires NCR Receptors.
A and B) Percent target cell cytotoxicity as measured by LDH assay. NK-92 cells were cocultured with
67NR or 66cl4 targets at a 5:1 E: T ratio with or without heparin. (n = 3,* = t-test p-value < 0.05).
C) Representative flow cytometry histograms of NCR1-Ig binding to 67NR and 66cl4.
D) qRT-PCR analysis of IL-2 expression in Ncr1-ζ, IL-2 reporter BW cells incubated with control or BPTF
KD 66CL4 and 67NR cell lines for 48 hrs (n ≥ 3, * = t-test p-value < 0.05).
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7.3 BPTF Regulates Cell Surface HS Abundance on HSPG and Heparanase
Expression.
HS (heparin sulfates), also known as HSGAGs (heparin sulfate
glycosaminoglycans), are members of the glycosaminoglycan family. HS are complex
polysaccharides that are characterized by a repeat disaccharide unit of iduronic or
glucuronic acid linked to a glucosamine. When the HS are covalently attached to
proteins, they are called heparin sulfate proteoglycans (HSPGs). Although HS are
expressed on the cell surface of both normal and tumor cells, their fine structure and
sequence are modulated in both cell types to play diverse roles (Ram et al., 2002). It
has been shown that the presence of HS on tumor cells induce NK cytotoxic activity
through engagement with NCRs (Hershkovitz et al., 2008 and Hecht et al., 2009). Our
microarray data (data not shown) revealed alteration in HS metabolism genes, which
encouraged us to look at the levels of HS on the cell surface of both Ctrl and BPTF KD
cells. As expected, the levels of HS were upregulated on the surface of BPTF KD 67NR
and 66cl4 targets when compared to Ctrl cells (Figure 7.6 A) suggesting that high levels
of HS on the surface of BPTF KD cells enhance NCR engagement and activate NK cell
cytotoxicity.
Heparanase is an endo-glycosidase that cleaves the HS side chain of HSPGs on
the cell surface. Heparanase is overexpressed in human tumors such as breast cancer
(Gomes et al., 2013), hepatocellular carcinoma (El-Assal et al., 2001) and gastric
cancers (Endo et al., 2001). Since it plays important roles in metastasis, angiogenesis
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and inflammation. The levels of heparanase affect many physiological processes in the
cell so its expression is tightly regulated (Nta et al., 2006).
So far, heparanase is the only known mammalian enzyme to regulate the levels
of HSPGs on cell surface (Fuxt al., 2009 and Caruana et al., 2015). In an attempt to
identify BPTF regulated genes that are involved in the regulation of HS on cell surface.
We investigated the levels of heparanase using qRT- PCR and Western blot analysis.
As shown in Figure 7.6 B, C, the levels of heparanase are substantially downregulated
at both the levels of RNA and protein in BPTF KD 67NR and 66cl4 when compared to
Ctrl. These data suggest that BPTF could directly regulate the levels of heparanase. To
test this hypothesis, we have conducted ChIP experiment, which revealed heparanase
promoter occupancy by BPTF supporting a direct role for BPTF in regulating the levels
of heparanase in 67NR and 66cl4 cell lines (Figure 7.6 D) (Kuo and Allis, 1999).
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Figure 7.6: BPTF Regulates Heparanase Expression
A) HSPG Western blot analysis of cell surface extracts using anti-HS primary mAb. Arrows indicate
reproducible changes in HSPG abundance with BPTF KD.
B) Heparanase Western blot analysis of cell surface extracts from control and BPTF KD cell lines.
C) qRT-PCR analysis of heparanase (HPSE) expression from 67NR and 66cl4 cells (n = 3, * = t-test pvalue < 0.006).
D) BPTF ChIP at the mouse heparanase’ promoter (n = 3, * = t-test p-value < 0.04).
This figure is done by Kimberly Mayes.
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7.4 BPTF Depletion Enhances the Immune Response to Established Tumors
In our transplantation experiments, we have used cell lines that constitutively
express BPTF-shRNAs. Therefore, we decided to determine the antitumor effect of
BPTF KD in established tumors. Toward this end, we constructed a replication-deficient
adenovirus (rADV) expressing control or BPTF KD shRNAs. The ability of rADV to
efficiently KD BPTF in both 66cl4 and 4T1 cells was first demonstrated in vitro (data not
shown). Both 66cl4 and 4T1 cell lines were inoculated into BALB/c and once the tumors
reached a palpable size (~5 mm), we started an intra-tumor injection with 1x109 PFU
rADV of either virus, three times a week for three weeks. BPTF levels in established
tumors were reduced in response to rADV treatment as measured by Western blotting
(Figure 7.7 A). BPTF KD in those tumors resulted in significant reduction in tumor
weight (Figure 7.7 B) and in some cases to complete tumor regression in 66cl4 tumors.
To evaluate the anti-tumor effect of BPTF KD, we measured the levels of infiltration and
activation of NK cells in 66cl4 tumors and CD8+ T cells 4T1 tumors, respectively. We
previously showed that BPTF KD enhances the CD8+ T cell response to 4T1 tumors
because of improved tumor antigenicity (Mayes et al., 2016). BPTF KD in established
tumors enhanced both NK and CD8+ T cells’ activity (Figure 7.7 C).
Active immune effector cells are characterized by cytokine secretion such as
IFNγ that modulate TME. To assess the ability of active of NK and CD8+ T cells for
cytokine secretion, we measured the levels of IFNγ in the TME. As illustrated in Figure
7.7 D, BPTF KD tumors exhibit high levels of IFNγ demonstrating a conversion to a Th1
TME. rADV injection into established tumors could KD BPTF in tumor and non-tumor
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cells. To monitor the effect of BPTF KD on NK cells and CD8 T cells, we transduced
NK92 cells and splenic mouse OT1 T cells with rADV to knock-down BPTF, which was
verified by Western blot analysis (Figure 7.8 A, C). After BPTF KD in NK-92 and OT1 T
cells, we measured their cytolytic activity in vitro. Results showed that BPTF KD did not
alter NK cells or T cell cytotoxic activity (Figure 7.8 B, D) indicating that rADV treatment
of established tumors did not compromise effector cell function.
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Figure 7.7: BPTF is Required for an Immune Suppressive Tumor Microenvironment.
A)BPTF Western blot analysis of 66cl4 and 4T1 tumors injected with replication-deficient adenovirus
(rADV) expressing either control (Ctrl-sh) or BPTF KD (Bptf-sh) shRNAs.
B) Weights of 66cl4 and 4T1 tumors after treatment with rADV (n ≥ 6, * = t-test p-value < 0.003).
C)Flow cytometry analysis of 66cl4 tumor infiltrating NK cells and 4T1 tumor infiltrating CD8+ T cells.
Active lymphocytes are quantified as percent CD69 high of total infiltrating NK cells (NKp46+) or CD8+ T
cells (CD8+) (n ≥ 4, * = t-test p-value < 0.01).
D) IFNγ concentrations from 66cl4 and 4T1 tumor extracts measured by ELISA (n ≥ 6, * = t-test p-value <
0.04).
This figure is done by Mark Roberts and Zeinab Elsayed.
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Figure 7.8: BPTF is Not Required for NK or CD8+ T Cell Cytolytic Activity.
A and C) BPTF Western blot analysis on total cell extracts from control and BPTF KD NK-92 or (c)
mouse OT1 T cells after rADV infection.
B and D) Percent target cell cytotoxicity. (B) NK-92 or (D) mouse OT1 T cells were incubated with
K562 cells for 4 hrs or B16F10-OVA targets or 24 hrs, respectively, at a 10:1 E: T ratio (n = 3).
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7.5 NK Cytolysis Activity Toward BPTF KD Cells is Conserved in Human
In a first step toward understanding the mechanism for the enhanced cytolytic
activity of NK cells to BPTF KD tumor cells, we determined if the effect is conserved
between mice and humans. Toward this end, we transduced the human breast
adenocarcinoma cell lines, T47D and MDA-MB-436, and the neuroblastoma cell line
SH-SY5Y with lentiviruses expressing control or BPTF shRNAs (Figure 7.9 A, B). These
human cell lines and the mouse 67NR and 66cl4 cell lines were cocultured with human
NK-92 cells, an immortalized human NK cell line (Gong et al., 1994), and monitored for
cytolytic activity. Similarly, we observed enhanced NK-92 cytolytic activity toward
human BPTF KD targets compared to controls (Figure 7.9 C). Moreover, the levels of
heparanase were also down regulated in these cells indicating that the mechanisms
leading to NK enhanced cytolytic activity are conserved.
Collectively, our data suggest a model for BPTF in the suppression of NK
antitumor activity as shown in Figure 7.10. BPTF is a positive regulator of heparanase in
67NR and 66cl4 cells and its depletion increases cell surface HSPG levels. HSPGs are
activating ligands for the NK cells activating receptor NCR1 (in mouse) and NKp30 (in
human), and their abundance on the cell surface made them better targets for NK cells
cytolytic activity. In addition, active NK cells secrete IFNγ, which promotes the Th1
response, which in turn secrete more IFNγ that activate APCs and recruit more immune
effector cells. We speculate that dead tumor cells in the TME result in more de novo
antigens and enhance CD8 T cells effector function upon presentation. The combined
effect of these responses promotes tumor elimination and host protection.
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Figure 7.9: NK Cytolysis Activity is Conserved in Human Cell Lines.
A) BPTF Western blot analysis of heparanase in control and BPTF KD T47D, MDA-MB-436 and SHSY5Y total cell extracts. This is done by Dr.Joseph Landry.
B) qRT-PCR analysis of heparanase expression in T47D, MDA-MB-436 and SH-SY5Y cells (n = 3, * = ttest p-value < 0.05). This is done by Kimberly Mayes.
C) NK-92 cells were co-cultured with T47D, MDA-MD-436 or SH-SY5Y at a 10:1 E: T ratio (n = 3, * = ttest p-value < 0.05).
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A Model for the Effect of BPTF KD in Anti-Tumor Immunity

Figure 7.10: A Model for BPTF Suppression of Anti-Tumor Activity.
In BPTF Ctrl cells, NURF stimulates heparanase expression, which consequently reduces cell surface
HSPGs (NCR1 co-ligand) abundance, inhibiting NK-cell antitumor activity. However, in BPTF KD cells,
heparanase levels are reduced resulting in elevated HSPGs on the cell surface and enhancement of NK
cell-mediated antitumor activity.
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Chapter 8
Discussion and Future Directions

Tumor immune evasion is an important step for cancer progression, which is
accomplished by acquiring genetic and epigenetic modifications. These changes can
result in defective antigen presentation, upregulation of immune suppressive mediators
and/or down regulation of NK ligands for activating receptors (Vinay et al., 2015).
Genetic changes are irreversible and occur at lower frequency than reversible
epigenetic changes making them appealing therapeutic targets (Kornel et al., 2007).
ATP dependent chromatin remodeling complexes are gate-keepers that regulate the
accessibility to DNA or histone modifiers predicting an essential role for these
complexes in cancer biology. To understand how the ATP dependent remodeling
complex NURF is involved in breast cancer progression, we used mouse transplantable
tumor models. In these models BPTF KD induced NK antitumor response and polarized
TME toward tumor rejection and eradication by inducing Th1 response.
BPTF is the largest and essential subunit of the NURF complex (Barak et al.,
2003, Xiao et al., 2001). BPTF is unique subunit for the NURF complex so; its
knockdown will not cause pleotropic effects that could complicate our results. BPTF has
a tumorigenic role in skin, lung, colon and liver (Dai et al., 2015, Xiao et al., 2015,
Buganim et al., 2010, Xiao et al., 2015). However, its exact role in breast cancer biology
is not well understood. To uncover its roles in breast cancer biology we used wellcharacterized mouse models of breast cancer. The cell lines used in this study (67NR,
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66cl4 and 4T1) were isolated from same tumor (Aslakson and Miller, 1992). Both 4T1
and 66cl4 cell lines are metastatic while 67NR is not. 4T1 is highly immunogenic and it
is characterized by high infiltration rate of suppressive immune cells such as immature
DCs, Tregs, MDSCs and both M1&M2 macrophages (Aslakson and Miller, 1992 and
Zaidi et al., 2011). However, the immunogenicity of both 67NR and 66cl4 is not defined.
BPTF knock-down in both immunogenic and non-immunogenic cell lines resulted in
reduced tumor weights suggesting that BPTF depletion can overcome immune
suppressive mechanisms developed by tumor cells. Our depletion experiments revealed
that NK are the major effector cells involved in the reduction of BPTF KD cells. NK cells
represent the key component of the innate immune system that recognize and eliminate
cancer cells. There is recent clinical and experimental evidence that NK cells are
critically involved in the immune surveillance of tumors (Waldhauer and Steinle 2008).
NK cell cytotoxic activity results from the integration of multiple activating and
inhibitory signals (Chester et al., 2015). We looked at the levels of NK inhibitory ligands
but they were expressed equally on both Ctrl and BPTF KD targets (data not shown).
We also tested the possibility that BPTF KD targets secrete a soluble factor to activate
NK cells. These experiments revealed that NK activity is due to a cell surface receptor
rather than a soluble ligand (data not shown). To complete cytotoxicity assays we took
advantage of NK-92, a highly cytotoxic human cell line that is IL-2-dependent (Guitta et
al., 2000). NK-92 express high levels of activating receptors such as NKp30, NKp46,
and 2B4, NKG2D, E and CD28 and the expression levels of cytotoxic molecules such
as perforins and-granzymes are also high (Guitta et al., 2000). Conversely, they
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express few inhibitory receptors like NKG2A/B very low levels of KIR2DL4 and ILT-2
lack most the killer inhibitory receptors (KIRs). The increased cytotoxic activity of NK-92
cells toward BPTF KD targets supports the presence of a conserved active receptorligand between mice and human that is responsible for their enhanced activity. These
results also excluded the possibility of an antibody dependent cell cytotoxicity (ADCC)
since NK-92 do not express the FC-gamma receptor.
Our microarray data support the role of BPTF in regulating HSPGs (data not
shown) leading us to a defined set of activating receptors on NK-92 cells (NCRsNKp30, NKp44 and NKp46) and their conserved homologue in mice NCR1. Antibody
blocking and heparin competitive inhibition experiments revealed that NKp30 (and
NCR1 in mice) is most likely to be the target receptor. The NKp30 is involved in the
crosstalk between NK cells and immature dendritic cells (iDCs) (Simhadri, and Reiners
et al. 2008). The cross-talk may either result in a reciprocal activation and maturation of
both cell types or in NK cell-dependent killing of immature dendritic cells, a mechanism
that limits the supply of antigen-presenting DCs to the immune response (Walzer, Dalod
et al. 2005). In this crosstalk, NKp30 on NK cells seems to be the driving and critical
receptor for both processes (Ferlazzo, Tsang et al. 2002; Vitale, Della Chiesa et al.
2005; Walzer, Dalod et al. 2005; Simhadri, Reiners et al. 2008).
We used two approaches to support our finding; the first approach was the use of
NCR-Fc soluble receptors that bind their cognate ligands if expressed on target cells.
Although the binding of both BPTF Ctrl and KD targets was similar, the second
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approach was enhancement of IL-2 expression in BW reporter cell line. Although both
Ctrl and BPTF KD targets bind equally to NCR1-Fc BPTF KD targets enhanced more
IL-2 expression when in contact with the Ncr1-zeta BW reporter line. This could be
explained by different glycosylation pattern of the Ncr1 receptor in BW and HEK-293
cells which results in differential ligand binding (Ariella et al., 2015). Another possibility
is that BPTF KD targets expresses adhesion molecules that synergize with NCR1 and
enhance IL-2 expression.
We have attributed the lower levels of HSPGs on BPTF Ctrl cells to higher
expression levels of heparanase. Higher levels of heparanase expression was
supported experimentally by Western blot and QPCR analysis. The BPTF dependent
regulation of heparanase could be direct due to the fact that BPTF occupies the
heparanase promoter region as illustrated by CHIP analysis. BPTF regulation of
heparanase expression could have broader implications since heparanase is involved in
many tumor promoting processes such as angiogenesis, metastasis, and inflammation
(Hammond et al., 2014). It has been shown that BPTF KD in melanoma tumors reduced
their metastatic potential (Dar et al., 2015). Our data suggest that BPTF could reduce
metastasis through heparanase regulation. The connection between BPTF depletion
and heparanase down-regulation and their effect on metastasis needs to be further
tested.
In our model, depletion of BPTF in established tumors overcame the
suppressive effect of TME and enhanced NK cytotoxic function. Antitumor activity of NK
cells could be direct or indirect. The direct effect of NK cells is lysis of tumor cells and
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secretion of IFNγ. IFNγ secretion in the TME can indirectly enhance Th1 cells to control
tumor growth (Ribas et al., 2003). In addition, because of IFNγ secretion, tumor cells
induce Fas expression and NK cells can kill them in a Fas ligand-dependent manner,
the lysis of tumor cells release de novo antigens, which in turn enhance tumor
antigenicity (Screpanti et al., 2001). Moreover, IFNγ stimulate the maturation of dendritic
cells, which promote strong and protective CD8 T cell response (Mocikat et al., 2003;
Adam et al., 2005). For 4T1 tumors, IFNγ is secreted by T cells, which can activate
antitumor T cells and promote the production of nitric oxide synthetase (Shankaran et
al., 2001). High levels of NO (nitric oxide) in the TME can directly induce apoptosis
through caspase activation, DNA fragmentation and chromatin condensation (Dimmeler
et al., 1997, Brune et al., 1998). Finally, BPTF depletion in 66cl4 or 4T1 tumors enhance
immune effector cells activity generating a positive feedback loop that helps in tumor
elimination (Heba et al., 2011).
BPTF depletion in 66cl4 tumors with rADV resulted in complete tumor regression
in about 18% of the mice. This regression was not observed in 4T1 tumors possibly due
to (i) 66cl4 tumors are infiltrated by significantly large number of NK cells, which upon
activation by BPTF depletion can completely eradicate tumors (Figure 7.2 A). In
addition, 4T1 cells is infiltrated by significant number of MDSCs, which are suppressive
immune cells. Although we treated the mice with gemcitabine (Le et al., 2009) to
eliminate MDSCs, the inability to achieve tumor regression could be a result of their
residual activity. In the future, we can try high concentration of the rADV to treat 4T1
tumors to get a similar response to 66cl4.
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BPTF depletion could synergize with other epigenetic modification inhibitors such
as the currently used DNMTi (DNA methyltransferase inhibitors). DNMTi are
demethylation agents that are known to induce the immune response by removing the
methylation suppressive effect on tumor antigens such as cancer testis antigens (CTAs)
and stimulating a CD8+ T cell response (James et al., 2006). DNMTis are also known to
induce heparanase expression possibly by promoting cancer biology (Ateeq et al.,
2008; Shteper et al., 2003). Combination of DNMTi and NURF inhibitors could possibly
inhibit heparanase upregulation, enhance CD8 T, cells and synergize with the beneficial
antitumor immune response by enhancing NK cells antitumor activities.
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